{
  "usdmVersion": "4.0",
  "generatedAt": "2025-11-30T01:40:16.267497",
  "generator": "Protocol2USDM v6.1",
  "study": {
    "id": "5f03f9ba-75a9-48b5-85cf-c29d733e77c4",
    "instanceType": "Study",
    "versions": [
      {
        "id": "828ddfd3-562c-4d0b-8f4a-148398871338",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "1510d8de-4cad-444b-a7b6-dfd8825cc6e0",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "e8d0b069-1a98-4bd0-8440-eeb2eafa9570",
              "standardCode": {
                "id": "de2289be-25ea-4d49-a0fd-d74b2b1ab027",
                "code": "Open Label",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Open Label",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Non-Randomized"
            },
            "arms": [
              {
                "id": "6c9345ef-d618-47cb-9d28-bb07b770715d",
                "name": "ALXN1840 Single-Arm",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Single-arm, open-label, repeat-dose administration of ALXN1840 initiated at 15 mg once daily for approximately 28 days, followed by intra-patient titration to 30 mg once daily on Day 29, with allowable dose modification between 15 mg every other day and 30 mg/day based on safety.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "8a66047a-bef2-4dde-ba97-7f28945d332f",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [
              {
                "id": "2e9dbdfb-3003-40eb-a92b-b01987d561b3",
                "name": "Cohort 1: Treatment-experienced",
                "instanceType": "StudyCohort",
                "characteristic": "Participants with Wilson disease who have received Wilson disease therapy (standard of care therapies or ALXN1840) for more than 28 days prior to enrollment."
              },
              {
                "id": "3046b261-87b8-47eb-ba0a-721327e86a61",
                "name": "Cohort 2: Treatment-naïve",
                "instanceType": "StudyCohort",
                "characteristic": "Participants with Wilson disease who have received Wilson disease therapy for 28 days or less prior to enrollment."
              }
            ],
            "studyCells": [
              {
                "id": "96de1521-f7d0-429e-8999-f78097ea049c",
                "armId": "6c9345ef-d618-47cb-9d28-bb07b770715d",
                "epochId": "9a7247ec-c9f2-4567-99dc-aebe9b72ff62",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "aaba1f56-013d-4ae3-a69e-64843930b2d0",
                "armId": "6c9345ef-d618-47cb-9d28-bb07b770715d",
                "epochId": "9d5c79b2-fed3-4df0-8cc1-a12459e611c3",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "8a96bd30-cd3e-4fd6-9b8a-e2cc289f6461",
                "armId": "6c9345ef-d618-47cb-9d28-bb07b770715d",
                "epochId": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "7578e550-9120-4253-b523-1b8f3a3176fc",
                "armId": "6c9345ef-d618-47cb-9d28-bb07b770715d",
                "epochId": "c6f9f1a4-4d8c-42c6-8b2e-2a19fc04db7f",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "fb3856c3-4524-40d5-86a7-7b26a378fa0d",
                "armId": "6c9345ef-d618-47cb-9d28-bb07b770715d",
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb",
                "elementIds": [],
                "instanceType": "StudyCell"
              },
              {
                "id": "4a9f8fcc-11bd-4bb1-8d4d-1f5184bcf708",
                "armId": "6c9345ef-d618-47cb-9d28-bb07b770715d",
                "epochId": "3939d4ed-903d-4a44-94b0-51282c72f843",
                "elementIds": [],
                "instanceType": "StudyCell"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "bc6c8030-b98f-4741-b838-de03aa590431",
                "identifier": "1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "eb24352d-493f-4ea9-97cf-6db8f601606b",
                "instanceType": "EligibilityCriterion",
                "name": "Age criterion",
                "nextId": "f92f934a-928d-4c90-9cf0-1304ecc59843"
              },
              {
                "id": "f92f934a-928d-4c90-9cf0-1304ecc59843",
                "identifier": "2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5f0c1194-df03-4442-a175-697914b36001",
                "instanceType": "EligibilityCriterion",
                "name": "Wilson disease diagnosis",
                "previousId": "bc6c8030-b98f-4741-b838-de03aa590431",
                "nextId": "531be677-dbd7-41ba-af6d-4e00efd23032"
              },
              {
                "id": "531be677-dbd7-41ba-af6d-4e00efd23032",
                "identifier": "3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "65ae0368-71cd-4839-ae00-065406962029",
                "instanceType": "EligibilityCriterion",
                "name": "Potential benefit from decoppering therapy",
                "previousId": "f92f934a-928d-4c90-9cf0-1304ecc59843",
                "nextId": "91363c01-b1b3-427b-8bf0-5c199f9c4aa2"
              },
              {
                "id": "91363c01-b1b3-427b-8bf0-5c199f9c4aa2",
                "identifier": "4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "fd50a0e2-f18e-4e8c-8680-1083153340bd",
                "instanceType": "EligibilityCriterion",
                "name": "Ability to comply with study procedures",
                "previousId": "531be677-dbd7-41ba-af6d-4e00efd23032",
                "nextId": "e7009dd3-dd43-42d9-aac4-5e7ae6dc4332"
              },
              {
                "id": "e7009dd3-dd43-42d9-aac4-5e7ae6dc4332",
                "identifier": "5",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "587f1f9d-58d3-4f48-8336-b51e03463d77",
                "instanceType": "EligibilityCriterion",
                "name": "Ability to reside in CRU",
                "previousId": "91363c01-b1b3-427b-8bf0-5c199f9c4aa2",
                "nextId": "9f8ba332-9bd2-42e2-9877-826c640af3b3"
              },
              {
                "id": "9f8ba332-9bd2-42e2-9877-826c640af3b3",
                "identifier": "6",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "72274f42-524d-4a10-9b2c-3fcb4ec76742",
                "instanceType": "EligibilityCriterion",
                "name": "Willingness to discontinue chelator therapy",
                "previousId": "e7009dd3-dd43-42d9-aac4-5e7ae6dc4332",
                "nextId": "75f8c3a2-1599-436f-83cc-25c3af06d079"
              },
              {
                "id": "75f8c3a2-1599-436f-83cc-25c3af06d079",
                "identifier": "7",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "92daf8d2-fbc0-40a6-bb64-5638ca24d2f9",
                "instanceType": "EligibilityCriterion",
                "name": "Adequate venous access",
                "previousId": "9f8ba332-9bd2-42e2-9877-826c640af3b3",
                "nextId": "a9acd01d-a710-465f-9ade-570ec01e681f"
              },
              {
                "id": "a9acd01d-a710-465f-9ade-570ec01e681f",
                "identifier": "8",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "c088100c-2d14-4520-9253-083db0241d8b",
                "instanceType": "EligibilityCriterion",
                "name": "Ability to swallow tablets",
                "previousId": "75f8c3a2-1599-436f-83cc-25c3af06d079",
                "nextId": "a83141b2-3596-415b-be7d-24de40110c8d"
              },
              {
                "id": "a83141b2-3596-415b-be7d-24de40110c8d",
                "identifier": "9",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8e048e79-5333-4212-b43a-0c4ab631aa82",
                "instanceType": "EligibilityCriterion",
                "name": "Avoidance of mineral supplements",
                "previousId": "a9acd01d-a710-465f-9ade-570ec01e681f",
                "nextId": "d0dc4761-3feb-4264-9c5a-d675e3adc2f8"
              },
              {
                "id": "d0dc4761-3feb-4264-9c5a-d675e3adc2f8",
                "identifier": "10",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "96cded92-94b2-4207-bf00-deab9a0f1ba8",
                "instanceType": "EligibilityCriterion",
                "name": "Dietary adherence",
                "previousId": "a83141b2-3596-415b-be7d-24de40110c8d",
                "nextId": "2990f03c-debf-4d40-beaf-6238b5de8cc5"
              },
              {
                "id": "2990f03c-debf-4d40-beaf-6238b5de8cc5",
                "identifier": "11",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2a0f4029-7466-4b76-9095-decd6e71a7df",
                "instanceType": "EligibilityCriterion",
                "name": "Contraceptive requirements",
                "previousId": "d0dc4761-3feb-4264-9c5a-d675e3adc2f8",
                "nextId": "1ab7804a-c275-43e3-aca2-d89b6307412d"
              },
              {
                "id": "1ab7804a-c275-43e3-aca2-d89b6307412d",
                "identifier": "12",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "1108aaaf-29e0-4509-852c-9728ba133f75",
                "instanceType": "EligibilityCriterion",
                "name": "Informed consent",
                "previousId": "2990f03c-debf-4d40-beaf-6238b5de8cc5"
              },
              {
                "id": "b6d9fa1d-3a3b-4b02-8c63-499203f69fa3",
                "identifier": "1",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "39b30775-cdcd-49ef-9e64-8d860fcfd771",
                "instanceType": "EligibilityCriterion",
                "name": "Decompensated cirrhosis / MELD score exclusion",
                "nextId": "3ea1376c-1544-4d64-bb0d-1cdbb87a1c54"
              },
              {
                "id": "3ea1376c-1544-4d64-bb0d-1cdbb87a1c54",
                "identifier": "2",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "60c90eb5-5a45-48c8-b3d1-950c77334d1b",
                "instanceType": "EligibilityCriterion",
                "name": "Modified Nazer score exclusion",
                "previousId": "b6d9fa1d-3a3b-4b02-8c63-499203f69fa3",
                "nextId": "36d35281-f1c9-4d5d-bede-1fa303aedf75"
              },
              {
                "id": "36d35281-f1c9-4d5d-bede-1fa303aedf75",
                "identifier": "3",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "4df8ceb3-3193-471d-a778-bf5ca1b1249b",
                "instanceType": "EligibilityCriterion",
                "name": "Recent GI bleed exclusion",
                "previousId": "3ea1376c-1544-4d64-bb0d-1cdbb87a1c54",
                "nextId": "fd0b3b78-b0c5-4c9c-8c9b-1e03432d54c9"
              },
              {
                "id": "fd0b3b78-b0c5-4c9c-8c9b-1e03432d54c9",
                "identifier": "4",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "56083761-eb64-46b2-8254-945e3f436fd1",
                "instanceType": "EligibilityCriterion",
                "name": "ALT elevation exclusion",
                "previousId": "36d35281-f1c9-4d5d-bede-1fa303aedf75",
                "nextId": "92edba3b-aee2-47f7-b427-d49d42a2a409"
              },
              {
                "id": "92edba3b-aee2-47f7-b427-d49d42a2a409",
                "identifier": "5",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "94b18ab0-1b8b-4b07-9549-ae9ee9a11955",
                "instanceType": "EligibilityCriterion",
                "name": "Severe neurological disease exclusion",
                "previousId": "fd0b3b78-b0c5-4c9c-8c9b-1e03432d54c9",
                "nextId": "dc15fca7-2cc0-4dd0-b485-f8e94ed73b9e"
              },
              {
                "id": "dc15fca7-2cc0-4dd0-b485-f8e94ed73b9e",
                "identifier": "6",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2530beee-382b-43dc-9f7c-d26a70e8b1a8",
                "instanceType": "EligibilityCriterion",
                "name": "Low hemoglobin exclusion",
                "previousId": "92edba3b-aee2-47f7-b427-d49d42a2a409",
                "nextId": "0f8ff67d-396b-4797-a69d-6de51f3a437a"
              },
              {
                "id": "0f8ff67d-396b-4797-a69d-6de51f3a437a",
                "identifier": "7",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "672ca9c0-d9ab-4cd5-91c6-43df930d0da3",
                "instanceType": "EligibilityCriterion",
                "name": "Viral infection/HIV exclusion",
                "previousId": "dc15fca7-2cc0-4dd0-b485-f8e94ed73b9e",
                "nextId": "c5d115e9-f772-4c7b-84a8-823db2321948"
              },
              {
                "id": "c5d115e9-f772-4c7b-84a8-823db2321948",
                "identifier": "8",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "139edadc-4a42-4fdb-a891-4eaed6dd3962",
                "instanceType": "EligibilityCriterion",
                "name": "Significant comorbid disorder exclusion",
                "previousId": "0f8ff67d-396b-4797-a69d-6de51f3a437a",
                "nextId": "d59ca501-5595-4cbd-bbee-815a0d4784bb"
              },
              {
                "id": "d59ca501-5595-4cbd-bbee-815a0d4784bb",
                "identifier": "9",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b48f7819-49f7-4d56-abee-fc39069744c3",
                "instanceType": "EligibilityCriterion",
                "name": "Prior ALXN1840/tetrathiomolybdate exclusion",
                "previousId": "c5d115e9-f772-4c7b-84a8-823db2321948",
                "nextId": "262fb793-e978-415c-9df1-e0e2e804937f"
              },
              {
                "id": "262fb793-e978-415c-9df1-e0e2e804937f",
                "identifier": "10",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b27735ae-f921-4262-92df-1210a001d55e",
                "instanceType": "EligibilityCriterion",
                "name": "Recent zinc treatment exclusion",
                "previousId": "d59ca501-5595-4cbd-bbee-815a0d4784bb",
                "nextId": "699b13c7-185b-4754-aa36-229d24df2d1f"
              },
              {
                "id": "699b13c7-185b-4754-aa36-229d24df2d1f",
                "identifier": "11",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8acf03fa-5ffc-40a1-8eb5-48aff9332659",
                "instanceType": "EligibilityCriterion",
                "name": "Recent experimental therapy exclusion",
                "previousId": "262fb793-e978-415c-9df1-e0e2e804937f",
                "nextId": "87809902-2369-4c31-9009-b0db89327b1b"
              },
              {
                "id": "87809902-2369-4c31-9009-b0db89327b1b",
                "identifier": "12",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8dc60302-de85-426a-85c7-5eab5538f8bc",
                "instanceType": "EligibilityCriterion",
                "name": "Renal failure exclusion",
                "previousId": "699b13c7-185b-4754-aa36-229d24df2d1f",
                "nextId": "5f764a54-7b04-4be9-9168-e46707127b26"
              },
              {
                "id": "5f764a54-7b04-4be9-9168-e46707127b26",
                "identifier": "13",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e349ca69-a84e-4260-9b24-504f5fb3fbb0",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy and breastfeeding exclusion",
                "previousId": "87809902-2369-4c31-9009-b0db89327b1b",
                "nextId": "0757d84b-d261-423e-93f3-1870b8d7cbe3"
              },
              {
                "id": "0757d84b-d261-423e-93f3-1870b8d7cbe3",
                "identifier": "14",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0532b8d0-f6ed-4461-b5d7-630f8739b3c2",
                "instanceType": "EligibilityCriterion",
                "name": "Hypersensitivity to ALXN1840",
                "previousId": "5f764a54-7b04-4be9-9168-e46707127b26",
                "nextId": "26e1e2c3-c5ca-42f8-9185-24d952b58290"
              },
              {
                "id": "26e1e2c3-c5ca-42f8-9185-24d952b58290",
                "identifier": "15",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b1ffbbde-6f6c-459a-b6b2-2f59fc1e8db3",
                "instanceType": "EligibilityCriterion",
                "name": "Non-compliance risk",
                "previousId": "0757d84b-d261-423e-93f3-1870b8d7cbe3",
                "nextId": "89bfbd6b-115b-4685-8f21-39b4d6df3ec0"
              },
              {
                "id": "89bfbd6b-115b-4685-8f21-39b4d6df3ec0",
                "identifier": "16",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0cab62cd-10a0-4dc6-9c73-702a0ed0ff41",
                "instanceType": "EligibilityCriterion",
                "name": "Drug/alcohol abuse history",
                "previousId": "26e1e2c3-c5ca-42f8-9185-24d952b58290",
                "nextId": "7ebf458b-8ee6-48e4-b5f6-b368197196bb"
              },
              {
                "id": "7ebf458b-8ee6-48e4-b5f6-b368197196bb",
                "identifier": "17",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "28bdfb19-2367-4a05-a566-fb151e4baf72",
                "instanceType": "EligibilityCriterion",
                "name": "Positive drug screen",
                "previousId": "89bfbd6b-115b-4685-8f21-39b4d6df3ec0",
                "nextId": "d68272b8-6d97-4873-a27b-60725edc5a79"
              },
              {
                "id": "d68272b8-6d97-4873-a27b-60725edc5a79",
                "identifier": "18",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "e5896c91-8078-48ed-992e-50d39b4fd57c",
                "instanceType": "EligibilityCriterion",
                "name": "Recent alcohol use / positive breath test",
                "previousId": "7ebf458b-8ee6-48e4-b5f6-b368197196bb",
                "nextId": "45ea7a6c-6cef-4c4d-83eb-656eeefb71e7"
              },
              {
                "id": "45ea7a6c-6cef-4c4d-83eb-656eeefb71e7",
                "identifier": "19",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "eed514db-50d8-4a74-a03e-8d280df250dd",
                "instanceType": "EligibilityCriterion",
                "name": "Inability to comply with controlled menu",
                "previousId": "d68272b8-6d97-4873-a27b-60725edc5a79"
              }
            ],
            "objectives": [
              {
                "id": "7a364118-559b-4b41-9bac-f4d342b853ac",
                "name": "Primary Objective",
                "text": "Assess net copper balance with daily repeat-dose ALXN1840 treatment (15 mg and 30 mg) in participants with Wilson disease (WD)",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "f1ddb29f-f4f4-43c1-86d4-a5b8e2ebb2a4"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "191356cf-6d96-4c81-a34e-678cc645b31d",
                "name": "Secondary Objective 1",
                "text": "Assess change in copper balance in response to ALXN1840 15 mg/day and 30 mg/day during ALXN1840 accumulation and at steady state periods versus the pretreatment baseline in participants with WD",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "5c368a7d-9529-42fe-9e5b-954a4354cf39"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "87f4d272-efca-43f3-a325-4cb2ed88cb78",
                "name": "Secondary Objective 2",
                "text": "Investigate the effect of ALXN1840 (15 mg/day and 30 mg/day) on the disposition of copper in participants with WD",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "8f8b6744-22ce-4641-b570-5ed2daa83341"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "417bf34d-a0bd-4481-933b-718f914a7fb4",
                "name": "Secondary Objective 3",
                "text": "Investigate the effect of ALXN1840 on the disposition of molybdenum at steady state at 15 mg/day and 30 mg/day in participants with WD",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "739fe9ec-e397-4506-a1a2-f43f8500a250"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "bb62d57f-2ab6-41bc-8641-8863de7096a7",
                "name": "Secondary Objective 4",
                "text": "Assess steady-state total molybdenum balance as a measure of ALXN1840 15 mg/day and 30 mg/day in participants with WD",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "8e752601-1553-4e94-9460-7dacc1b5d4fa"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "b3cb7970-eaa1-4c1c-92bc-9f231fae9c1f",
                "name": "Secondary Objective 5",
                "text": "Assess accumulation of molybdenum with ALXN1840 treatment at 15 mg/day and 30 mg/day in participants with WD",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "cafd037d-6461-4d24-9e35-4d70acbe4108"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "5ac7432d-53a2-47d3-a824-2661dfdb3ad0",
                "name": "Secondary Objective 6",
                "text": "Determine the steady-state plasma pharmacokinetic (PK) of total molybdenum and plasma ultrafiltrate (PUF) molybdenum (as surrogate measures of ALXN1840, 15 mg and 30 mg) in participants with WD",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "a9a15245-6cb9-4f55-978c-4d43cb499a4e"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "dcfaac51-ff1c-4028-b5ff-36c994227618",
                "name": "Safety Objective",
                "text": "Evaluate the safety and tolerability of repeated-dose administration of ALXN1840 15 mg/day and 30 mg/day in participants with WD",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "9e099525-db01-42a5-977e-e9d91bf5cf93"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "31a7fe66-6092-469d-828d-05f9b61a0484",
                "name": "Exploratory Objective 1",
                "text": "Determine dose response of ALXN1840 15 mg/day and 30 mg/day for copper balance in participants with WD",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "c47df377-cef1-43b2-bd37-273b6054068e"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "4e69ace3-e75c-4877-97f7-080e0165be2f",
                "name": "Exploratory Objective 2",
                "text": "Determine the effect of treatment duration on copper balance in participants with WD",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "7f964f5a-d763-4dc2-a895-61b98aa1afeb"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "85ad0e6d-3ed4-47c4-a2a5-5353925197b9",
                "name": "Exploratory Objective 3",
                "text": "Assess the effects of ALXN1840 on ceruloplasmin, ceruloplasmin-bound copper LBC profiles in plasma in participants with WD",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "bf5f5e72-d680-4351-8861-bc5820ddb87b"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "f1ddb29f-f4f4-43c1-86d4-a5b8e2ebb2a4",
                "name": "Primary Endpoint",
                "text": "Mean daily copper balance where copper balance is measured by the calculated difference between copper intake (in food and drink) and copper output (in feces and urine) during ALXN1840 accumulation and steady-state periods for each dose",
                "level": {
                  "id": "C98770",
                  "code": "C98770",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Planned Country of Investigational Site",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "5c368a7d-9529-42fe-9e5b-954a4354cf39",
                "name": "Secondary Endpoint 1",
                "text": "Change in mean daily copper balance as measured by the calculated difference between copper intake (in food and drink) and copper output (in feces and urine) from pretreatment baseline (Days -4 through -1) and ALXN1840 accumulation and steady-state periods for each dose",
                "level": {
                  "id": "C98784",
                  "code": "C98784",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Stifle Joint",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "8f8b6744-22ce-4641-b570-5ed2daa83341",
                "name": "Secondary Endpoint 2",
                "text": "Copper quantified in food, drink, feces, and urine, including plasma total and labile bound copper (LBC) during ALXN1840 accumulation and steady-state periods for each dose",
                "level": {
                  "id": "C98784",
                  "code": "C98784",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Stifle Joint",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "739fe9ec-e397-4506-a1a2-f43f8500a250",
                "name": "Secondary Endpoint 3",
                "text": "Molybdenum quantified in food, drink, feces, and urine, plasma total molybdenum at ALXN1840 steady state",
                "level": {
                  "id": "C98784",
                  "code": "C98784",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Stifle Joint",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "8e752601-1553-4e94-9460-7dacc1b5d4fa",
                "name": "Secondary Endpoint 4",
                "text": "Mean daily molybdenum balance as demonstrated through measurement of molybdenum intake (in food, drink and ALXN1840), and molybdenum output (feces and urine) representing ALXN1840 steady state",
                "level": {
                  "id": "C98784",
                  "code": "C98784",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Stifle Joint",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "cafd037d-6461-4d24-9e35-4d70acbe4108",
                "name": "Secondary Endpoint 5",
                "text": "Accumulation of molybdenum as determined by molybdenum balance",
                "level": {
                  "id": "C98784",
                  "code": "C98784",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Stifle Joint",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "a9a15245-6cb9-4f55-978c-4d43cb499a4e",
                "name": "Secondary Endpoint 6",
                "text": "PK parameters for plasma total and PUF-molybdenum",
                "level": {
                  "id": "C98784",
                  "code": "C98784",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Stifle Joint",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "9e099525-db01-42a5-977e-e9d91bf5cf93",
                "name": "Safety Endpoint",
                "text": "Safety parameters:\n• Treatment emergent adverse events (TEAEs)/serious adverse events (SAEs)\n• Clinical laboratory assessments (serum chemistry, hematology, coagulation, and urinalysis)\n• Physical examinations\n• Heart rate, intervals (PR, QRS, QT and QTc), and clinically significant electrocardiogram (ECG) findings as determined by triplicate 12-lead ECG\n• Vital sign assessments (blood pressure and heart rate)",
                "level": {
                  "id": "C98784",
                  "code": "C98784",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Stifle Joint",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "c47df377-cef1-43b2-bd37-273b6054068e",
                "name": "Exploratory Endpoint 1",
                "text": "Assess dose response of ALXN1840 on copper balance focusing on copper balance",
                "level": {
                  "id": "C157551",
                  "code": "C157551",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Minor Histocompatibility Antigen HA-1",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "7f964f5a-d763-4dc2-a895-61b98aa1afeb",
                "name": "Exploratory Endpoint 2",
                "text": "Determine the effect of time following initiation of ALXN1840 treatment on copper balance",
                "level": {
                  "id": "C157551",
                  "code": "C157551",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Minor Histocompatibility Antigen HA-1",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "bf5f5e72-d680-4351-8861-bc5820ddb87b",
                "name": "Exploratory Endpoint 3",
                "text": "Ceruloplasmin, ceruloplasmin-bound copper, and LBC: Change in ceruloplasmin at Days 1, 8, 25, 29, 36, and Day 39 compared with predose",
                "level": {
                  "id": "C157551",
                  "code": "C157551",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Minor Histocompatibility Antigen HA-1",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              }
            ],
            "studyInterventions": [
              {
                "id": "16c81105-c21e-49b8-9b17-153c4e813206",
                "name": "ALXN1840",
                "role": {
                  "id": "7d49ca97-204f-4d09-b42c-7b7da62a4dd1",
                  "code": "Investigational Product",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Investigational Product",
                  "instanceType": "Code"
                },
                "instanceType": "StudyIntervention",
                "description": "Oral bis-choline tetrathiomolybdate administered once daily at 15 mg and 30 mg doses to participants with Wilson disease",
                "productIds": [
                  "05d9a79b-91ac-47e9-84a0-2c1483b383fd"
                ],
                "administrationIds": [
                  "19a045ef-d049-4d61-ab8c-316371962c1e"
                ]
              },
              {
                "id": "41f9fd6f-9be1-433f-a4a7-a46735d540cb",
                "name": "Copper- and molybdenum-controlled diet",
                "role": {
                  "id": "04b6a875-4763-419f-ad20-9bcb6c889f58",
                  "code": "Background Therapy",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Background Therapy",
                  "instanceType": "Code"
                },
                "instanceType": "StudyIntervention",
                "description": "Standardized copper- and molybdenum-controlled meals provided during inpatient periods to control dietary copper and molybdenum intake",
                "administrationIds": [
                  "ad9dcf47-c788-4605-918d-8ceb5554ef4f"
                ]
              }
            ],
            "scheduleTimelines": [
              {
                "id": "3493e15b-e5c0-408c-b1e1-0b1a25e59d6a",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "b9664a67-9d64-4ef7-aae7-6d6e3d2c766f",
                "instances": [
                  {
                    "id": "b9664a67-9d64-4ef7-aae7-6d6e3d2c766f",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_1",
                    "encounterId": "29d90854-0a33-428c-be2b-4284a920f49b"
                  },
                  {
                    "id": "f100f794-94e5-4046-b6c7-56d6ed8a274e",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_3",
                    "encounterId": "fffb09be-d1ca-4e6c-b8ea-2a7c9d96521b"
                  },
                  {
                    "id": "89107f1d-1a53-4a0a-846f-efbb3e10d326",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "420d78ea-f311-4c1e-9859-7e36be8b816c",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_10",
                    "encounterId": "1643c1a3-15d5-4d59-aab5-be1cdbb164b1"
                  },
                  {
                    "id": "db4771be-4718-4090-95bb-c30d85eee69b",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_12",
                    "encounterId": "30391c61-ebd9-4bfb-8114-b222c3612a50"
                  },
                  {
                    "id": "1ea6c26d-bf07-435b-af03-98a8c4daaea9",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_13",
                    "encounterId": "202dbacd-cc9d-4886-9c69-771fcb00e426"
                  },
                  {
                    "id": "b629333f-4574-4527-abb8-ec4bad538f78",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_16",
                    "encounterId": "d963ddc7-ad25-4600-b6d8-aae82ed8e9fd"
                  },
                  {
                    "id": "17796e3e-c101-4476-8eb8-a4527dcf801a",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_18",
                    "encounterId": "be0a27f3-a496-4e32-9942-800e94df1250"
                  },
                  {
                    "id": "cde78325-dacd-4d5d-a7f7-c214f6f53930",
                    "activityId": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "5488f7fb-d68b-4438-8f6e-5e8dd595e1b7",
                    "activityId": "0e425476-7911-4607-a9f3-0d32e064a8aa",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@pt_1",
                    "encounterId": "29d90854-0a33-428c-be2b-4284a920f49b"
                  },
                  {
                    "id": "70762a71-1e55-4110-a211-f72772b37012",
                    "activityId": "0e425476-7911-4607-a9f3-0d32e064a8aa",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@pt_3",
                    "encounterId": "fffb09be-d1ca-4e6c-b8ea-2a7c9d96521b"
                  },
                  {
                    "id": "f0303601-24c7-4a56-b226-810c505329a8",
                    "activityId": "0e425476-7911-4607-a9f3-0d32e064a8aa",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@pt_7",
                    "encounterId": "d2906f70-4cff-4cd4-8f14-8463bb1988a5"
                  },
                  {
                    "id": "40cf2a29-4e69-46ac-b972-932436fa11de",
                    "activityId": "0e425476-7911-4607-a9f3-0d32e064a8aa",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@pt_10",
                    "encounterId": "1643c1a3-15d5-4d59-aab5-be1cdbb164b1"
                  },
                  {
                    "id": "d663dc19-c8e7-4675-904a-85e234f4b771",
                    "activityId": "0e425476-7911-4607-a9f3-0d32e064a8aa",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@pt_12",
                    "encounterId": "30391c61-ebd9-4bfb-8114-b222c3612a50"
                  },
                  {
                    "id": "17cdb4b4-35b8-47a4-a74c-a45fba3d0c8a",
                    "activityId": "0e425476-7911-4607-a9f3-0d32e064a8aa",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@pt_19",
                    "encounterId": "9db57fa7-3f63-4dc7-8cff-8f50fd40879a"
                  },
                  {
                    "id": "b575000e-4c5c-49de-96f2-b36cd41bbf66",
                    "activityId": "0e425476-7911-4607-a9f3-0d32e064a8aa",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "d63de9d3-83ea-4f05-b83d-92502bfdc061",
                    "activityId": "21c2bf4c-c2ea-4778-80e8-f6ba8c53a4e7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@pt_1",
                    "encounterId": "29d90854-0a33-428c-be2b-4284a920f49b"
                  },
                  {
                    "id": "9a7659ba-4e93-46f2-b02f-9b59ae3a19f3",
                    "activityId": "21c2bf4c-c2ea-4778-80e8-f6ba8c53a4e7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@pt_3",
                    "encounterId": "fffb09be-d1ca-4e6c-b8ea-2a7c9d96521b"
                  },
                  {
                    "id": "31471c80-a09f-42ce-8bc4-80366122a277",
                    "activityId": "21c2bf4c-c2ea-4778-80e8-f6ba8c53a4e7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@pt_11",
                    "encounterId": "34fb76fc-b198-4cc8-b122-32cbf01bc6e1"
                  },
                  {
                    "id": "3130bbf4-f95a-4ed1-a5a6-64bfe8668d0f",
                    "activityId": "21c2bf4c-c2ea-4778-80e8-f6ba8c53a4e7",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@pt_24",
                    "encounterId": "8ddb6316-3727-4351-aa84-6e3abe5245cc"
                  },
                  {
                    "id": "77ad923d-4e14-4c19-9882-6d47417e3c46",
                    "activityId": "6ee8d2b4-f106-49d4-93bc-2f7ed4d64963",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@pt_3",
                    "encounterId": "fffb09be-d1ca-4e6c-b8ea-2a7c9d96521b"
                  },
                  {
                    "id": "8c2e68c7-518d-4eeb-b8c7-8fe1c399fe92",
                    "activityId": "cb251cbb-d603-47cb-8231-5932b6885fd8",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@pt_1",
                    "encounterId": "29d90854-0a33-428c-be2b-4284a920f49b"
                  },
                  {
                    "id": "4adc7524-25f2-401c-ab80-de6f36ba8333",
                    "activityId": "cb251cbb-d603-47cb-8231-5932b6885fd8",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@pt_4",
                    "encounterId": "98a3ffa6-c771-44fe-b194-55f2a8c14239"
                  },
                  {
                    "id": "69d161b8-0547-4efc-8876-9839d38deaac",
                    "activityId": "cb251cbb-d603-47cb-8231-5932b6885fd8",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "611328a1-89ea-486d-a9da-c0dbe3bd5599",
                    "activityId": "cb251cbb-d603-47cb-8231-5932b6885fd8",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@pt_10",
                    "encounterId": "1643c1a3-15d5-4d59-aab5-be1cdbb164b1"
                  },
                  {
                    "id": "453b1158-70f5-4688-af05-e3c6206a8ccc",
                    "activityId": "cb251cbb-d603-47cb-8231-5932b6885fd8",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@pt_11",
                    "encounterId": "34fb76fc-b198-4cc8-b122-32cbf01bc6e1"
                  },
                  {
                    "id": "7fa77131-1f24-484e-b273-97b7408fbfb7",
                    "activityId": "cb251cbb-d603-47cb-8231-5932b6885fd8",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@pt_24",
                    "encounterId": "8ddb6316-3727-4351-aa84-6e3abe5245cc"
                  },
                  {
                    "id": "5ccda423-02c2-4863-9e14-da3c1d7520cf",
                    "activityId": "31aca375-8f4c-4306-a552-88aec2f3018b",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@pt_1",
                    "encounterId": "29d90854-0a33-428c-be2b-4284a920f49b"
                  },
                  {
                    "id": "7b5fc68f-48ff-4f9e-b740-cf845aa3d63d",
                    "activityId": "31aca375-8f4c-4306-a552-88aec2f3018b",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@pt_4",
                    "encounterId": "98a3ffa6-c771-44fe-b194-55f2a8c14239"
                  },
                  {
                    "id": "2127a9c9-a875-4683-a5bb-585c92faa6e2",
                    "activityId": "31aca375-8f4c-4306-a552-88aec2f3018b",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "8538dc00-d66b-47ce-a605-7fc437a1ffa3",
                    "activityId": "31aca375-8f4c-4306-a552-88aec2f3018b",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@pt_10",
                    "encounterId": "1643c1a3-15d5-4d59-aab5-be1cdbb164b1"
                  },
                  {
                    "id": "792a4766-3d79-4c6b-8813-88de9f103445",
                    "activityId": "31aca375-8f4c-4306-a552-88aec2f3018b",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@pt_11",
                    "encounterId": "34fb76fc-b198-4cc8-b122-32cbf01bc6e1"
                  },
                  {
                    "id": "b69bcd45-12c2-4759-956f-685ba3bd3ae8",
                    "activityId": "31aca375-8f4c-4306-a552-88aec2f3018b",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@pt_21",
                    "encounterId": "ea515c15-d068-4a85-a23c-305df3d1a747"
                  },
                  {
                    "id": "a04ff4cd-c07b-4942-a99d-9862255d11df",
                    "activityId": "31aca375-8f4c-4306-a552-88aec2f3018b",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_6@pt_24",
                    "encounterId": "8ddb6316-3727-4351-aa84-6e3abe5245cc"
                  },
                  {
                    "id": "5e7b9e81-eeb9-49ed-806e-7baae0353e9d",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_1",
                    "encounterId": "29d90854-0a33-428c-be2b-4284a920f49b"
                  },
                  {
                    "id": "7960dc7e-9df2-4f56-af63-8de6494c4270",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_2",
                    "encounterId": "e4a54bd6-4067-4485-b5cd-7171951cfce5"
                  },
                  {
                    "id": "c3d264b5-9a5c-48f2-afb7-a4f2b217dfb3",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_3",
                    "encounterId": "fffb09be-d1ca-4e6c-b8ea-2a7c9d96521b"
                  },
                  {
                    "id": "4b755496-8267-4778-940f-22043d104810",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_4",
                    "encounterId": "98a3ffa6-c771-44fe-b194-55f2a8c14239"
                  },
                  {
                    "id": "f5a49c96-29ee-4270-97fd-769a689fc638",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_5",
                    "encounterId": "a9b9a41e-d184-4fde-90a4-edb04fa22c34"
                  },
                  {
                    "id": "790fa2cd-d56b-44f6-9e7c-e4c584d16c90",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "7e432166-dfcc-460f-8908-831c9fd52e7d",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_7",
                    "encounterId": "d2906f70-4cff-4cd4-8f14-8463bb1988a5"
                  },
                  {
                    "id": "b692e337-c24e-4956-88a9-2cb927096516",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_8",
                    "encounterId": "5d7a1a87-d79f-4a33-8a68-4946fd266b52"
                  },
                  {
                    "id": "05d7df96-4cf7-4b92-bc7b-9c61c8258c72",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_9",
                    "encounterId": "7ca010a7-2320-4290-abc7-62bb932d287e"
                  },
                  {
                    "id": "0caf34da-3178-43ec-81f2-e8d2d6bd4717",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_10",
                    "encounterId": "1643c1a3-15d5-4d59-aab5-be1cdbb164b1"
                  },
                  {
                    "id": "39c3e4e0-4062-4c1a-b8ae-f8969ea84c0d",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_11",
                    "encounterId": "34fb76fc-b198-4cc8-b122-32cbf01bc6e1"
                  },
                  {
                    "id": "829b548a-8f86-4e46-b97e-633469da66cf",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_12",
                    "encounterId": "30391c61-ebd9-4bfb-8114-b222c3612a50"
                  },
                  {
                    "id": "b160c8c7-4007-4f09-b67e-1c1900b29abb",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_13",
                    "encounterId": "202dbacd-cc9d-4886-9c69-771fcb00e426"
                  },
                  {
                    "id": "ccfefd16-30f2-4e3f-a812-91ef05c5d0a8",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_14",
                    "encounterId": "ae94d315-c043-4ebc-bebe-4837fb444c9d"
                  },
                  {
                    "id": "978f1a86-4506-4319-8c6d-483d0d182466",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_15",
                    "encounterId": "093ede2a-57ce-43ab-b7c9-bdcedcca078a"
                  },
                  {
                    "id": "ba896faa-d04a-408e-9376-fa313de12d5b",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_16",
                    "encounterId": "d963ddc7-ad25-4600-b6d8-aae82ed8e9fd"
                  },
                  {
                    "id": "ec99d377-1fc9-4e2f-a30e-398ab1a0da21",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_17",
                    "encounterId": "f28cbc31-b8b3-4698-96b9-4f3302697fc0"
                  },
                  {
                    "id": "d55cea8b-f063-4676-a55c-f696494dcbad",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_18",
                    "encounterId": "be0a27f3-a496-4e32-9942-800e94df1250"
                  },
                  {
                    "id": "42b5ec07-e2a2-4eac-82b4-a3ad253fa64d",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_19",
                    "encounterId": "9db57fa7-3f63-4dc7-8cff-8f50fd40879a"
                  },
                  {
                    "id": "c9dc98c8-407b-4a4f-90b5-e54e3d410d6e",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_20",
                    "encounterId": "dc4ee77b-ac17-453f-9f29-0462ef674b1f"
                  },
                  {
                    "id": "b266f333-d57a-49af-acb7-39534fd7d5e9",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_21",
                    "encounterId": "ea515c15-d068-4a85-a23c-305df3d1a747"
                  },
                  {
                    "id": "c471b371-2cc8-4064-adb2-debdd58220f2",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "984d2ce1-81b8-44d7-a18b-aa36f4d0be8b",
                    "activityId": "a8a00715-3f6c-475c-97ac-b850818858dc",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_7@pt_24",
                    "encounterId": "8ddb6316-3727-4351-aa84-6e3abe5245cc"
                  },
                  {
                    "id": "d42686ca-023f-40df-9335-689862f201c1",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_4",
                    "encounterId": "98a3ffa6-c771-44fe-b194-55f2a8c14239"
                  },
                  {
                    "id": "15bfd099-bb64-4cbf-bb3a-bce2859d2aa2",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_5",
                    "encounterId": "a9b9a41e-d184-4fde-90a4-edb04fa22c34"
                  },
                  {
                    "id": "177a474f-fb23-4890-a291-3a1df3e3a7dd",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "0eb04a1c-5fd0-4ca8-97e9-53e40d13b6f2",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_7",
                    "encounterId": "d2906f70-4cff-4cd4-8f14-8463bb1988a5"
                  },
                  {
                    "id": "a10aa8b1-5fb4-42a1-abd5-6b4bca6e7745",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_8",
                    "encounterId": "5d7a1a87-d79f-4a33-8a68-4946fd266b52"
                  },
                  {
                    "id": "b90c7620-ec87-4db2-8e06-239db47e1f6d",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_9",
                    "encounterId": "7ca010a7-2320-4290-abc7-62bb932d287e"
                  },
                  {
                    "id": "63617db7-a913-4625-8f44-741603db2677",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_13",
                    "encounterId": "202dbacd-cc9d-4886-9c69-771fcb00e426"
                  },
                  {
                    "id": "ce5c98cf-80d6-4a06-804f-662e68a0b3ab",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_14",
                    "encounterId": "ae94d315-c043-4ebc-bebe-4837fb444c9d"
                  },
                  {
                    "id": "4af91465-b151-427c-8fff-b2007464aaf2",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_15",
                    "encounterId": "093ede2a-57ce-43ab-b7c9-bdcedcca078a"
                  },
                  {
                    "id": "a4db1d91-c369-4fef-9cd1-d40713fe3870",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_16",
                    "encounterId": "d963ddc7-ad25-4600-b6d8-aae82ed8e9fd"
                  },
                  {
                    "id": "7db9f8b4-2448-40e7-822d-4f1b57830db2",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_17",
                    "encounterId": "f28cbc31-b8b3-4698-96b9-4f3302697fc0"
                  },
                  {
                    "id": "f8c6920d-a68f-4a2b-8827-2b02b0985af8",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_18",
                    "encounterId": "be0a27f3-a496-4e32-9942-800e94df1250"
                  },
                  {
                    "id": "1ee95853-fc30-42b3-b11d-0a6548f7ed84",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_19",
                    "encounterId": "9db57fa7-3f63-4dc7-8cff-8f50fd40879a"
                  },
                  {
                    "id": "2f526ff8-1eb9-4072-89e8-f33334658588",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_20",
                    "encounterId": "dc4ee77b-ac17-453f-9f29-0462ef674b1f"
                  },
                  {
                    "id": "d229f555-5aec-437e-ae79-bc19288808c5",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_21",
                    "encounterId": "ea515c15-d068-4a85-a23c-305df3d1a747"
                  },
                  {
                    "id": "f73dead1-2c06-4944-8948-be2a4cdf3b29",
                    "activityId": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_8@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "03772686-ecfa-4978-a1f0-59e3f4a03e55",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_4",
                    "encounterId": "98a3ffa6-c771-44fe-b194-55f2a8c14239"
                  },
                  {
                    "id": "b225f608-2d7c-4e83-9485-8fc0cbda6ab2",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_5",
                    "encounterId": "a9b9a41e-d184-4fde-90a4-edb04fa22c34"
                  },
                  {
                    "id": "6d857264-46da-472a-a4be-c604da1ab838",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "4bc63402-590f-4a8f-b394-5a8755d1efba",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_7",
                    "encounterId": "d2906f70-4cff-4cd4-8f14-8463bb1988a5"
                  },
                  {
                    "id": "ca91a129-e969-46eb-9817-2aebc7e8ae6b",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_8",
                    "encounterId": "5d7a1a87-d79f-4a33-8a68-4946fd266b52"
                  },
                  {
                    "id": "2f1804fd-ecd5-44fd-a3f0-dd018e51c885",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_9",
                    "encounterId": "7ca010a7-2320-4290-abc7-62bb932d287e"
                  },
                  {
                    "id": "002dced3-5015-48ff-aa31-b536bb5d2749",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_10",
                    "encounterId": "1643c1a3-15d5-4d59-aab5-be1cdbb164b1"
                  },
                  {
                    "id": "a2bcfd34-9e03-4e87-bae1-5b6012e13070",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_11",
                    "encounterId": "34fb76fc-b198-4cc8-b122-32cbf01bc6e1"
                  },
                  {
                    "id": "d6c35cb7-909a-458d-bda9-c05c73822357",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_12",
                    "encounterId": "30391c61-ebd9-4bfb-8114-b222c3612a50"
                  },
                  {
                    "id": "0324645c-c6e8-4659-bfe0-f7c001b83b38",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_13",
                    "encounterId": "202dbacd-cc9d-4886-9c69-771fcb00e426"
                  },
                  {
                    "id": "449dc984-597d-48c6-8ef7-ccf69a958fb4",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_14",
                    "encounterId": "ae94d315-c043-4ebc-bebe-4837fb444c9d"
                  },
                  {
                    "id": "3741ef7d-2f20-47ed-a92f-6952f8d51c99",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_15",
                    "encounterId": "093ede2a-57ce-43ab-b7c9-bdcedcca078a"
                  },
                  {
                    "id": "600ebec6-2424-4328-86bc-b48aaab6316d",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_16",
                    "encounterId": "d963ddc7-ad25-4600-b6d8-aae82ed8e9fd"
                  },
                  {
                    "id": "f59ab20d-e122-4405-b650-8e82cc95755d",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_17",
                    "encounterId": "f28cbc31-b8b3-4698-96b9-4f3302697fc0"
                  },
                  {
                    "id": "e70471b4-e1d4-4ecc-b2e8-677287d81b84",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_18",
                    "encounterId": "be0a27f3-a496-4e32-9942-800e94df1250"
                  },
                  {
                    "id": "705e7b16-ec7a-441c-a654-8bbe0fdc55e8",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_19",
                    "encounterId": "9db57fa7-3f63-4dc7-8cff-8f50fd40879a"
                  },
                  {
                    "id": "60d025a1-c66e-47bc-9bc5-e3448a746c70",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_20",
                    "encounterId": "dc4ee77b-ac17-453f-9f29-0462ef674b1f"
                  },
                  {
                    "id": "7f229e48-2ece-46e5-af10-e6c88e812b59",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_21",
                    "encounterId": "ea515c15-d068-4a85-a23c-305df3d1a747"
                  },
                  {
                    "id": "3cfe3e6a-a9f0-46e3-ba20-eb77b2cc7660",
                    "activityId": "act9",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act9@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "30a749ce-4df2-4828-8713-21def2407062",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "f2bcac65-95ae-4eef-b86e-6677d7ea4ed8",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_7",
                    "encounterId": "d2906f70-4cff-4cd4-8f14-8463bb1988a5"
                  },
                  {
                    "id": "c9365103-d699-479e-9ad7-29436c7fd779",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_8",
                    "encounterId": "5d7a1a87-d79f-4a33-8a68-4946fd266b52"
                  },
                  {
                    "id": "6659880c-8113-4e63-8977-de967724c4b5",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_9",
                    "encounterId": "7ca010a7-2320-4290-abc7-62bb932d287e"
                  },
                  {
                    "id": "9cb90815-805b-4279-a7c1-ffc75f967e3c",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_13",
                    "encounterId": "202dbacd-cc9d-4886-9c69-771fcb00e426"
                  },
                  {
                    "id": "8a4e01c2-ffed-4815-9640-cbe4725681a9",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_14",
                    "encounterId": "ae94d315-c043-4ebc-bebe-4837fb444c9d"
                  },
                  {
                    "id": "c4b68fbf-95c3-4f38-812f-cc62a1388e21",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_15",
                    "encounterId": "093ede2a-57ce-43ab-b7c9-bdcedcca078a"
                  },
                  {
                    "id": "7cf25fd1-82dd-4745-8789-d6f170905173",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_16",
                    "encounterId": "d963ddc7-ad25-4600-b6d8-aae82ed8e9fd"
                  },
                  {
                    "id": "2f517458-b262-4410-8db8-04aba2a52936",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_17",
                    "encounterId": "f28cbc31-b8b3-4698-96b9-4f3302697fc0"
                  },
                  {
                    "id": "22a49e12-a4ad-448d-9201-b6b6c285ff84",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_18",
                    "encounterId": "be0a27f3-a496-4e32-9942-800e94df1250"
                  },
                  {
                    "id": "71aac9f9-f339-4c63-ae3f-4ff8375ce897",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_19",
                    "encounterId": "9db57fa7-3f63-4dc7-8cff-8f50fd40879a"
                  },
                  {
                    "id": "429e8bb2-ae01-44e0-9431-b51dd5531f3b",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_20",
                    "encounterId": "dc4ee77b-ac17-453f-9f29-0462ef674b1f"
                  },
                  {
                    "id": "cd75124d-b6e1-42bb-9b72-27acbf43370b",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_21",
                    "encounterId": "ea515c15-d068-4a85-a23c-305df3d1a747"
                  },
                  {
                    "id": "a300da8e-1ea1-4bcf-9d21-7d43975d3335",
                    "activityId": "act10",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act10@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "fe94f548-4530-4eea-aea4-d3ab91abff44",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "a46f264d-b72e-490f-8517-d204c596b284",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_7",
                    "encounterId": "d2906f70-4cff-4cd4-8f14-8463bb1988a5"
                  },
                  {
                    "id": "640b9673-434a-4649-87eb-5634793a0b0d",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_8",
                    "encounterId": "5d7a1a87-d79f-4a33-8a68-4946fd266b52"
                  },
                  {
                    "id": "ac630398-8d9a-4cc4-8ed2-2ec9ecea0fab",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_9",
                    "encounterId": "7ca010a7-2320-4290-abc7-62bb932d287e"
                  },
                  {
                    "id": "eeea61a6-67c0-41f1-8aa3-345cced103a8",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_13",
                    "encounterId": "202dbacd-cc9d-4886-9c69-771fcb00e426"
                  },
                  {
                    "id": "417e1090-7c87-4159-8a97-fafe20979cf7",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_14",
                    "encounterId": "ae94d315-c043-4ebc-bebe-4837fb444c9d"
                  },
                  {
                    "id": "eae20c15-4293-455a-a183-a90fd660cb3a",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_15",
                    "encounterId": "093ede2a-57ce-43ab-b7c9-bdcedcca078a"
                  },
                  {
                    "id": "a724e417-4029-4fc2-9540-3e5a636a6068",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_16",
                    "encounterId": "d963ddc7-ad25-4600-b6d8-aae82ed8e9fd"
                  },
                  {
                    "id": "08a64ebd-e7ca-4954-9685-8655a2eb68e0",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_17",
                    "encounterId": "f28cbc31-b8b3-4698-96b9-4f3302697fc0"
                  },
                  {
                    "id": "7cd0dc6a-9c23-47ba-8f69-41fe612870a9",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_18",
                    "encounterId": "be0a27f3-a496-4e32-9942-800e94df1250"
                  },
                  {
                    "id": "218aeb44-62b5-46ff-98f0-5cb5cb59a333",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_19",
                    "encounterId": "9db57fa7-3f63-4dc7-8cff-8f50fd40879a"
                  },
                  {
                    "id": "baab5111-0024-4b88-bf79-070db1b604b2",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_20",
                    "encounterId": "dc4ee77b-ac17-453f-9f29-0462ef674b1f"
                  },
                  {
                    "id": "2166ffef-ec14-49c6-9d1b-6c14a4bbb82e",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_21",
                    "encounterId": "ea515c15-d068-4a85-a23c-305df3d1a747"
                  },
                  {
                    "id": "f0728362-1b14-481f-bba1-90e6b10b58f5",
                    "activityId": "act11",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act11@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "cba96f17-f885-426d-907d-f92ce64e3cf4",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "18534b3c-76da-4fb0-8816-84fade93059e",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_7",
                    "encounterId": "d2906f70-4cff-4cd4-8f14-8463bb1988a5"
                  },
                  {
                    "id": "aa22b416-d529-427f-a779-199ac3626d1f",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_8",
                    "encounterId": "5d7a1a87-d79f-4a33-8a68-4946fd266b52"
                  },
                  {
                    "id": "148047a0-e919-4f86-b1bb-e21bc6e9ed52",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_9",
                    "encounterId": "7ca010a7-2320-4290-abc7-62bb932d287e"
                  },
                  {
                    "id": "aa06fb42-7bf2-4b3a-8ff4-f8c2ede5230e",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_13",
                    "encounterId": "202dbacd-cc9d-4886-9c69-771fcb00e426"
                  },
                  {
                    "id": "dc23d9db-ea0c-4aba-bc50-44c94f447991",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_14",
                    "encounterId": "ae94d315-c043-4ebc-bebe-4837fb444c9d"
                  },
                  {
                    "id": "454f358d-2cab-4d82-a2d5-aaaa5d83ca47",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_15",
                    "encounterId": "093ede2a-57ce-43ab-b7c9-bdcedcca078a"
                  },
                  {
                    "id": "673e25c7-9954-4d4c-83a2-5fb7c5f55382",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_16",
                    "encounterId": "d963ddc7-ad25-4600-b6d8-aae82ed8e9fd"
                  },
                  {
                    "id": "ee7d5344-0884-442a-b5ff-55fd1a0de481",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_17",
                    "encounterId": "f28cbc31-b8b3-4698-96b9-4f3302697fc0"
                  },
                  {
                    "id": "78ba3727-7545-4fdf-9ca5-3fbe4e7c36a4",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_18",
                    "encounterId": "be0a27f3-a496-4e32-9942-800e94df1250"
                  },
                  {
                    "id": "bf7b77a6-bbd9-4a01-a9c0-16435686d866",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_19",
                    "encounterId": "9db57fa7-3f63-4dc7-8cff-8f50fd40879a"
                  },
                  {
                    "id": "7ea2b1e8-564e-45a4-9fbc-456c3d2bb8bb",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_20",
                    "encounterId": "dc4ee77b-ac17-453f-9f29-0462ef674b1f"
                  },
                  {
                    "id": "e909c3e3-bc43-4614-8f21-6eb2f26f3da3",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_21",
                    "encounterId": "ea515c15-d068-4a85-a23c-305df3d1a747"
                  },
                  {
                    "id": "3dde3dce-5413-4f3e-b292-9409e7da9c94",
                    "activityId": "act12",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act12@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "dd01776b-4505-4c6a-8ffb-0fcea40f47ee",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_1",
                    "encounterId": "29d90854-0a33-428c-be2b-4284a920f49b"
                  },
                  {
                    "id": "4c105030-c9c1-482c-8f23-88b367fbdeec",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_2",
                    "encounterId": "e4a54bd6-4067-4485-b5cd-7171951cfce5"
                  },
                  {
                    "id": "a5a0f033-59e9-4d30-b9c0-fff37392467a",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_3",
                    "encounterId": "fffb09be-d1ca-4e6c-b8ea-2a7c9d96521b"
                  },
                  {
                    "id": "16b620e3-21d4-4bfe-83f6-d0b6af7cad90",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_4",
                    "encounterId": "98a3ffa6-c771-44fe-b194-55f2a8c14239"
                  },
                  {
                    "id": "f106a36f-78a6-4c3d-b232-3c9da19c1ae5",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_5",
                    "encounterId": "a9b9a41e-d184-4fde-90a4-edb04fa22c34"
                  },
                  {
                    "id": "4b8d0fc4-2360-40ee-935f-0c5cbd141a0f",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_6",
                    "encounterId": "7c5fa46c-28c3-4875-91dc-7fab3cf31876"
                  },
                  {
                    "id": "aa763567-7e3e-4682-b396-949856d4d991",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_7",
                    "encounterId": "d2906f70-4cff-4cd4-8f14-8463bb1988a5"
                  },
                  {
                    "id": "ff9dd4e9-50f0-45d1-b880-08467aae69cc",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_8",
                    "encounterId": "5d7a1a87-d79f-4a33-8a68-4946fd266b52"
                  },
                  {
                    "id": "87c2f5f9-08d3-405c-963b-b7175be0f325",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_9",
                    "encounterId": "7ca010a7-2320-4290-abc7-62bb932d287e"
                  },
                  {
                    "id": "dd09dde3-5557-4760-abb2-6ecb4be9d8a1",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_10",
                    "encounterId": "1643c1a3-15d5-4d59-aab5-be1cdbb164b1"
                  },
                  {
                    "id": "37a8e14d-a174-4a61-b18d-a87782f7173a",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_11",
                    "encounterId": "34fb76fc-b198-4cc8-b122-32cbf01bc6e1"
                  },
                  {
                    "id": "f0140546-d235-4e27-8b90-fe8bf96d4a9b",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_12",
                    "encounterId": "30391c61-ebd9-4bfb-8114-b222c3612a50"
                  },
                  {
                    "id": "3e89da01-f68b-4d56-bad6-b754041fd867",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_13",
                    "encounterId": "202dbacd-cc9d-4886-9c69-771fcb00e426"
                  },
                  {
                    "id": "90ceefa5-1402-498a-a748-052bceb518fc",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_14",
                    "encounterId": "ae94d315-c043-4ebc-bebe-4837fb444c9d"
                  },
                  {
                    "id": "309f9549-b537-42af-adf7-8361e5bc2f65",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_15",
                    "encounterId": "093ede2a-57ce-43ab-b7c9-bdcedcca078a"
                  },
                  {
                    "id": "93e4c81e-44cd-4dcd-99d7-3810c9b017a9",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_16",
                    "encounterId": "d963ddc7-ad25-4600-b6d8-aae82ed8e9fd"
                  },
                  {
                    "id": "9eeb73dc-074c-4dc3-9818-1a6e57f6c00c",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_17",
                    "encounterId": "f28cbc31-b8b3-4698-96b9-4f3302697fc0"
                  },
                  {
                    "id": "c0892d7e-4ab7-4380-ab1c-874a359d6f86",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_18",
                    "encounterId": "be0a27f3-a496-4e32-9942-800e94df1250"
                  },
                  {
                    "id": "1c144420-565b-48a3-ba11-38d8d37bb5d7",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_19",
                    "encounterId": "9db57fa7-3f63-4dc7-8cff-8f50fd40879a"
                  },
                  {
                    "id": "cf2dbbd2-516e-4b3f-8fb8-ed3976678d07",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_20",
                    "encounterId": "dc4ee77b-ac17-453f-9f29-0462ef674b1f"
                  },
                  {
                    "id": "074eeacb-7a5e-477a-86ec-2699eca0cd36",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_21",
                    "encounterId": "ea515c15-d068-4a85-a23c-305df3d1a747"
                  },
                  {
                    "id": "5730a386-1f7e-49b9-9209-c58b961ca433",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_22",
                    "encounterId": "9a958103-953e-43c3-a364-2ffbf5eb21cc"
                  },
                  {
                    "id": "44964b08-d87d-44fa-95fc-80c73faee643",
                    "activityId": "act13",
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act13@pt_24",
                    "encounterId": "8ddb6316-3727-4351-aa84-6e3abe5245cc"
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "609c8a46-c92d-44da-bea4-8258cafbfd91",
                "name": "Screening (Screening -42 to -9)",
                "instanceType": "Encounter",
                "type": {
                  "id": "780a5980-cab7-4696-8496-f61f6ca3167a",
                  "code": "C48262",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening",
                  "instanceType": "Code"
                },
                "epochId": "9a7247ec-c9f2-4567-99dc-aebe9b72ff62"
              },
              {
                "id": "1ff3ccc3-e947-47c0-bd97-56e93dd1eb31",
                "name": "Screening (C-1 -21)",
                "instanceType": "Encounter",
                "type": {
                  "id": "31dcf0a1-8eda-46d2-a63b-6c0a89b8577e",
                  "code": "C48262",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening",
                  "instanceType": "Code"
                },
                "epochId": "9d5c79b2-fed3-4df0-8cc1-a12459e611c3"
              },
              {
                "id": "9fbd54f5-72f7-492d-a34c-edf79cfe5cdd",
                "name": "Inpatient Period 1 (Day -8)",
                "instanceType": "Encounter",
                "type": {
                  "id": "1e603056-1cd5-471f-85ed-56f85f375332",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77"
              },
              {
                "id": "d0a1f13c-a6e6-481d-87ba-bada037ab1f4",
                "name": "Inpatient Period 1 (Day -7)",
                "instanceType": "Encounter",
                "type": {
                  "id": "59ede5e7-d716-441e-83b7-2174dad386d0",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77"
              },
              {
                "id": "25b4a453-0a95-4705-a639-b5781c70b733",
                "name": "Inpatient Period 1 (Day -6 through -5)",
                "instanceType": "Encounter",
                "type": {
                  "id": "3599fa46-fb4a-434b-847e-a9004c70ca6d",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77"
              },
              {
                "id": "9d3a381f-60d0-4063-ad49-616594b67d8d",
                "name": "Inpatient Period 1 (Day -4 through -1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "0e8f014b-186e-406b-959b-9895edcb8b3e",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77"
              },
              {
                "id": "e8033ddc-7539-4e0f-b1f4-feca340a9d02",
                "name": "Inpatient Period 1 (Day 1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "54a7464a-7c13-4579-8f17-fbfac58b464f",
                  "code": "C82517",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Baseline",
                  "instanceType": "Code"
                },
                "epochId": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77"
              },
              {
                "id": "213fe404-2c8e-4252-b885-7193c9fe41aa",
                "name": "Inpatient Period 1 (Days 2-3)",
                "instanceType": "Encounter",
                "type": {
                  "id": "c0845154-800a-4f2a-a635-7ba39651cc1d",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77"
              },
              {
                "id": "ac64b2c1-a32a-46a1-9d50-4936a8e18c4e",
                "name": "Inpatient Period 1 (Days 4-7)",
                "instanceType": "Encounter",
                "type": {
                  "id": "c26549ef-9686-4b48-86bd-9d3f1b29d6de",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77"
              },
              {
                "id": "d23be35c-8994-481b-8608-94a20e874d3a",
                "name": "OP (Day 8)",
                "instanceType": "Encounter",
                "type": {
                  "id": "c1069330-adfe-4ef8-b1b5-14e1cfdf696a",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "c6f9f1a4-4d8c-42c6-8b2e-2a19fc04db7f"
              },
              {
                "id": "8651366e-ef80-46de-b8b4-277b59b368a6",
                "name": "OP (Day 9)",
                "instanceType": "Encounter",
                "type": {
                  "id": "1f554634-362b-46ad-bd10-76c3a6648cbb",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "c6f9f1a4-4d8c-42c6-8b2e-2a19fc04db7f"
              },
              {
                "id": "ff4376ec-1ddc-4635-a7ad-51e0c3f24851",
                "name": "OP (Days 10-22)",
                "instanceType": "Encounter",
                "type": {
                  "id": "c1ccc530-9ef4-4bae-a9c7-a7d38f7c8c80",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "c6f9f1a4-4d8c-42c6-8b2e-2a19fc04db7f"
              },
              {
                "id": "57b19a61-88d4-4704-850f-000f93449e93",
                "name": "Inpatient Period 2 (Day 23)",
                "instanceType": "Encounter",
                "type": {
                  "id": "250ef1fd-fd22-4315-ba34-245b87517f29",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "4bfbb25b-56a9-48dd-8b2f-25c973e4797a",
                "name": "Inpatient Period 2 (Day 24)",
                "instanceType": "Encounter",
                "type": {
                  "id": "06d83bc7-b688-4efb-955e-a254979bb599",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "43fc5eb0-77da-4e14-903a-733d8cf6ec58",
                "name": "Inpatient Period 2 (Day 25)",
                "instanceType": "Encounter",
                "type": {
                  "id": "0709b271-247c-46ff-b518-2aec13b189a6",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "1a4227c3-61cc-4037-9623-7dd50af2a554",
                "name": "Inpatient Period 2 (Days 26-28)",
                "instanceType": "Encounter",
                "type": {
                  "id": "de069732-e749-4928-a8dc-c455bc17f77c",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "e8391343-f826-4d1f-9a51-472fb8ec07af",
                "name": "Inpatient Period 2 (Day 29)",
                "instanceType": "Encounter",
                "type": {
                  "id": "d06ffb8f-0ffe-481e-9202-3ac324aba024",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "24b71f1a-d41c-4bda-a90e-70ced4288dfb",
                "name": "Inpatient Period 2 (Days 30-35)",
                "instanceType": "Encounter",
                "type": {
                  "id": "dd6f3c62-4868-47e7-b533-d4167d558e41",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "4580f433-1d12-4b60-96c9-dfa23e800d33",
                "name": "Inpatient Period 2 (Day 36)",
                "instanceType": "Encounter",
                "type": {
                  "id": "abb1b5ad-66af-4af9-92f3-35cf0863f934",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "65bc058f-99ac-4ba5-b6c1-76144d0f6c51",
                "name": "Inpatient Period 2 (Days 37-38)",
                "instanceType": "Encounter",
                "type": {
                  "id": "faf00723-191a-40b6-b9c8-fc2f3aa29b64",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "7f882fd7-2618-4a61-aa1b-1de21100bd86",
                "name": "Inpatient Period 2 (Day 39)",
                "instanceType": "Encounter",
                "type": {
                  "id": "277d6e77-b9b5-4edb-9926-9d4487979978",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "f1956709-dccf-4e0a-bda2-996352464a90",
                "name": "Inpatient Period 2 (Day 40)",
                "instanceType": "Encounter",
                "type": {
                  "id": "ca7f73bd-4bc7-45ea-91ab-06bd233f91c8",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "4c487982-1b20-41be-bc9a-7a64e72de4fb"
              },
              {
                "id": "4b19318c-cfce-41d1-9ff4-c0484c7ad91f",
                "name": "UNS (UNS column)",
                "instanceType": "Encounter",
                "type": {
                  "id": "8d3c6887-f3f2-45c7-9520-cb16dd49658d",
                  "code": "C99156",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Scheduled Visit",
                  "instanceType": "Code"
                },
                "epochId": "3939d4ed-903d-4a44-94b0-51282c72f843"
              },
              {
                "id": "5aaed206-3c7b-4d1b-8b2d-ca2b03444a08",
                "name": "EOS or ET (EOS Day 54+/−2)",
                "instanceType": "Encounter",
                "type": {
                  "id": "7a91fddf-7684-4d48-a158-a628e37570b8",
                  "code": "C126070",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "End of Study",
                  "instanceType": "Code"
                },
                "epochId": "bbe6051e-980d-454d-b95f-a7432948524a"
              }
            ],
            "activities": [
              {
                "id": "230850f9-8d7b-4c27-940a-4475259eae03",
                "name": "Safety Assessments / Laboratory Analyses",
                "instanceType": "Activity",
                "childIds": [
                  "0e425476-7911-4607-a9f3-0d32e064a8aa",
                  "31aca375-8f4c-4306-a552-88aec2f3018b"
                ]
              },
              {
                "id": "f9308ffc-91d5-463f-8341-928f8877c03d",
                "name": "Balance assessments",
                "instanceType": "Activity",
                "childIds": [
                  "57481d0a-9ad3-4368-91c2-3537f5033339"
                ]
              },
              {
                "id": "69851dd0-f188-49e9-a313-16dc83f7757a",
                "name": "Other",
                "instanceType": "Activity",
                "childIds": [
                  "8ddb4a9c-c7ef-4488-bf53-7de9b54046b7"
                ]
              },
              {
                "id": "8c122e8a-e9b2-4ad6-aeea-801b971a66c7",
                "name": "Chemistryq, hematology, Coagulation",
                "instanceType": "Activity",
                "description": "Clinical laboratory assessments including serum chemistry, hematology, and coagulation parameters"
              },
              {
                "id": "0e425476-7911-4607-a9f3-0d32e064a8aa",
                "name": "Urinalysis",
                "instanceType": "Activity",
                "description": "Clinical laboratory urinalysis"
              },
              {
                "id": "21c2bf4c-c2ea-4778-80e8-f6ba8c53a4e7",
                "name": "Urine/serum pregnancy tests",
                "instanceType": "Activity",
                "description": "Urine or serum pregnancy testing"
              },
              {
                "id": "6ee8d2b4-f106-49d4-93bc-2f7ed4d64963",
                "name": "Retained serum sample (safety)t",
                "instanceType": "Activity",
                "description": "Retained serum sample for safety evaluation"
              },
              {
                "id": "cb251cbb-d603-47cb-8231-5932b6885fd8",
                "name": "Vitals sign measurementsu",
                "instanceType": "Activity",
                "description": "Vital signs measurements including body temperature, heart rate, respiratory rate, and blood pressure"
              },
              {
                "id": "31aca375-8f4c-4306-a552-88aec2f3018b",
                "name": "12-lead ECG (triplicate)",
                "instanceType": "Activity",
                "description": "Triplicate 12-lead electrocardiogram"
              },
              {
                "id": "a8a00715-3f6c-475c-97ac-b850818858dc",
                "name": "Adverse events",
                "instanceType": "Activity",
                "description": "Assessment and recording of adverse events"
              },
              {
                "id": "9f2c2b29-d9bb-4418-a401-00e19c18f197",
                "name": "Cu/Mo-controlled mealsv",
                "instanceType": "Activity",
                "description": "Copper- and molybdenum-controlled meals"
              },
              {
                "id": "57481d0a-9ad3-4368-91c2-3537f5033339",
                "name": "Light exercise regimen",
                "instanceType": "Activity",
                "description": "Light exercise regimen"
              },
              {
                "id": "9187f094-9613-4137-b3e5-7624b00b74a2",
                "name": "Urination and bowel movement monitoring, menstruation checks",
                "instanceType": "Activity",
                "description": "Monitoring of urination and bowel movements, and menstruation checks"
              },
              {
                "id": "1ce0b385-037b-469b-b988-0060aca6d936",
                "name": "24-hour urine for Cu and Mow",
                "instanceType": "Activity",
                "description": "24-hour urine collection for copper and molybdenum"
              },
              {
                "id": "e77a9acc-b24d-45a4-863d-9538685f393a",
                "name": "Feces for Cu and Mox",
                "instanceType": "Activity",
                "description": "Fecal collection for copper and molybdenum"
              },
              {
                "id": "8ddb4a9c-c7ef-4488-bf53-7de9b54046b7",
                "name": "Concomitant medication and non-pharmacologic therapy/procedure",
                "instanceType": "Activity",
                "description": "Documentation of concomitant medication and non-pharmacologic therapy or procedure"
              }
            ],
            "epochs": [
              {
                "id": "9a7247ec-c9f2-4567-99dc-aebe9b72ff62",
                "name": "Screening",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "a3157ef0-bb66-42a6-a697-986d4b72d0a6",
                  "code": "C98779",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Screening Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "9d5c79b2-fed3-4df0-8cc1-a12459e611c3",
                "name": "C-1b",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "6bd8fe43-a50d-424d-8f80-6617aba6c3bb",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "1c5ce973-f616-456a-9b0d-0fe0b26a1b77",
                "name": "Inpatient Period 1",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "2e58e5c2-733d-404c-a93c-876c9150f4ce",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "c6f9f1a4-4d8c-42c6-8b2e-2a19fc04db7f",
                "name": "OPc",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "95ca1bff-4f59-49da-8ff1-2daee2c356a8",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "4c487982-1b20-41be-bc9a-7a64e72de4fb",
                "name": "Inpatient Period 2",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "a7292f25-b74d-4e01-a596-628aae3b0141",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "3939d4ed-903d-4a44-94b0-51282c72f843",
                "name": "UNSd",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "d8735663-7bcf-4335-b1cc-7e9438eb066c",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                }
              },
              {
                "id": "bbe6051e-980d-454d-b95f-a7432948524a",
                "name": "EOS or ETe",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "06935c56-e756-40e9-8030-92494675b728",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                }
              }
            ],
            "notes": [
              {
                "id": "80fffac5-64c2-444a-b86b-b9bf0c21f1c3",
                "text": "a Within 42 days of ALXN1840 administration. Details of procedures that may be performed by sites designated as “screening sites” (only in the US) are detailed in Section 8.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "8670d161-e5e5-4545-bb6a-ebbc6744c9dc",
                "text": "b Participants will be admitted to the clinical research unit (CRU) at least 10 hours prior to enrollment and initiation of copper- and molybdenum-controlled diet.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "5303ea41-23f3-4323-bdf5-640130f92df3",
                "text": "c At the CRU’s discretion, participants may remain in the CRU or be readmitted on Day 22 with all procedures starting on Day 23.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "3329ba71-eb2d-4fc3-95e0-6c390e6c271a",
                "text": "d Unscheduled study visits may occur at any time during the study and may include any study procedure as deemed necessary by the Investigator.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "91ca9d29-a02c-4151-bb78-0de62030b626",
                "text": "e Participants are required to return to the CRU Day 54+/−2; participants will be discontinued from ALXN1840 medication by their physician at the latest by the Day 54 follow-up.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a8f10bb7-14f0-40ca-adce-a9ba79439840",
                "text": "f Discharge from the unit may occur after completion of all procedures on Day 9 and on Day 40 and after the Investigator has reviewed all safety assessment (including safety laboratory tests) and confirmed that the participant is appropriate for discharge.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "1bff625e-029c-4168-af29-5ff30bb8bfba",
                "text": "g A single outpatient visit or phone call and safety laboratory assessment should occur between Day 14 and Day 18. A phone call may take place on a different day than the blood draw within the Day 14 through Day 18 period.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "e7099ce2-1c49-4bcc-9e55-1104312e25d9",
                "text": "h If needed to confirm menopause.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "c40a7d9f-ba3f-4b3c-93da-b5b67391c67c",
                "text": "i Parameters include age and sex. Race and ethnicity will be collected where permitted by local regulations.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "7da010e8-77fe-4a94-a5d5-d8b7021b316f",
                "text": "j Wilson disease history will include diagnosis date, method of diagnosis, history of cirrhosis, details of any previous liver biopsies performed, and treatment received.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "5ca4c7bc-0545-42ad-9d6e-8f55f54854f2",
                "text": "k A full physical examination will be performed at Screening, at check-in for the study, and at the End of the study/Early Termination Visit. A physical examination should also be performed on any participants with ongoing adverse events prior to discharge from the unit. Otherwise, a symptom-driven physical examination may be performed at other times, at the Principal Investigator’s discretion.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "1efc78e2-df5a-4a1f-885b-3d8fd4c3320f",
                "text": "l Height at screening only.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "f6581938-8da0-418e-a716-791112816ae9",
                "text": "m While in the CRU, study intervention will be administered after an overnight fast (ie, at least 10 hours) at the same time every morning; drug is to be administered with 240 mL of water and meals should be delayed a minimum of 2 hours after dosing. As an outpatient, participants are expected to take ALXN1840 at approximately the same time daily (+/−1 hour). Participants should take the medication with a glass of water on an empty stomach; meals should be delayed a minimum of 2 hours after dosing.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "1cb9b72c-cbc3-4858-867a-81be46b0e72a",
                "text": "n During the outpatient period, participants will use SMS text messaging to confirm study intervention administration.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "98ee7857-a0ac-4ee4-9c12-41ea4decba6b",
                "text": "o Blood sampling for PK/PD will occur before ALXN1840 administration and represents a predose trough. See Table 2 for PK/PD sampling on Days 1, 25, 29, and 39.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "fd599636-13f9-4a13-93e2-3c5d24142c56",
                "text": "p PK/PD collection will include timepoints described in the schedule of PK/PD assessment for Days 1, 25, 29, and 39 (Table 2).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "bbb58578-7afe-49bd-b225-bc3685b409b1",
                "text": "q Samples for serum chemistry will be obtained following a fast of at least 8 hours at the Screening Visit and at check-in. In case of rechecks, and postdose serum chemistry, participants may not have fasted for 6 or 8 hours before the serum chemistry sample is taken.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "c9711447-a4f7-4648-9e01-1cd46ad68915",
                "text": "r Laboratory assessment including chemistry, hematology, and coagulation parameters should be performed on Days -8, -1, 8, 23, and 28 only.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "9e499491-cfd5-4548-b319-3f8d27326f3f",
                "text": "s Menstruation check is for women only; women of childbearing potential should only be enrolled after a negative serum pregnancy test result at Screening. Additional urine pregnancy testing will be standard for the protocol unless serum testing is required by site policies, local regulation, or Institutional Review Boards (IRBs)/Independent Ethics Committees (IECs) (Section 10.2). In addition to pregnancy tests detailed at the visits in the SoA, females of childbearing potential will be required to perform urine pregnancy tests at least every 4 weeks at their home or the study site throughout their time in the study.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "63baa300-dc29-44ee-904a-0fa18f01a42f",
                "text": "t A single 15 mL serum sample will be retained for evaluation in the event of an unexpected safety finding; retained samples may be destroyed after completion of the clinical study report.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "d9229042-9f44-4595-bcee-996fb26dce2f",
                "text": "u Vital signs measurements and ECGs should be performed before dosing, unless otherwise specified. Vitals signs include body temperature, heart rate, respiratory rate, and systolic and diastolic blood pressure.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "d4245db3-c9cc-4a5c-83cf-69973c116ab2",
                "text": "v Copper- and molybdenum-controlled diet will be initiated after registration/inclusion. Participants will remain on a copper/molybdenum controlled diet throughout both the inpatient Period 1 (Day 8 to Day 9) and inpatient Period 2 (Day 23 to Day 40); during this time participants will be strongly encouraged to eat all meals. While not in the CRU, participants will be encouraged to adhere to their usual copper-controlled diet.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "4dfe6472-6384-4130-8347-a382df87974a",
                "text": "w For each input/output balance period, 24-hour urine samples are to be collected for measurement of copper and molybdenum.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "76a11d6e-8d88-4495-8e79-106ee8915ef0",
                "text": "x For fecal samples, each individual sample will be independently collected with record of date, time, and weight of the sample.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "1140cedc-d6a7-4ed9-9f10-b9ad988b9215",
                "text": "y Abbreviations: AE = adverse event; BMI = body mass index; C-1 = check-in; Cu = copper; D = day; ECG = electrocardiogram; EOS/ET = End of Study or Early Termination; HIV = human immunodeficiency virus; HR = heart rate; LBC = labile bound copper; Mo = molybdenum; OP = outpatient; PD = pharmacodynamic; PK = pharmacokinetics; PUF = plasma ultrafiltrate; UNS = unscheduled; WD = Wilson disease.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "7a4ac836-fdc7-4c49-944a-c345b511e427",
                "text": "Table 2 note: Time point (hours)a: a Time points are relative to dosing (0 hours).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "61d6f09f-37ec-47de-a37c-70a3f0a1387a",
                "text": "Table 2 note: b Hour 24 PK/PD sampling is to occur just prior to the next-day dose of ALXN1840.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "52a3dfdd-292d-4754-8ded-ccd5157101e9",
                "text": "Table 2 abbreviations: Cu = copper; LBC = labile bound copper; Mo = molybdenum; PD = pharmacodynamic; PK = pharmacokinetic; PUF = plasma ultrafiltrate.",
                "instanceType": "CommentAnnotation"
              }
            ],
            "model": {
              "id": "aa6d2f97-737c-43c7-b6f8-00e19002091c",
              "code": "C82638",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Single Group Study",
              "instanceType": "Code"
            }
          }
        ],
        "titles": [
          {
            "id": "f81b7ba1-f986-4754-a324-74e206fa8308",
            "text": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
            "type": {
              "id": "f263ba10-0913-4f9a-b19c-4645430553b2",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "69eb589a-d36a-4b83-8085-4aaa10afa594",
            "text": "Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
            "type": {
              "id": "4ded9281-b38f-4e94-bf32-4fe6106a1963",
              "code": "Brief Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Brief Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "f46cddd3-64af-4dfa-869b-f667571adff1",
            "text": "ALXN1840-WD-204",
            "scopeId": "599a1e2a-4c9a-4cb9-beb7-91e3ebbd1580",
            "instanceType": "StudyIdentifier"
          },
          {
            "id": "c5f60fc4-82f6-47e4-90f9-db542fe57db4",
            "text": "2020-001104-41",
            "scopeId": "599a1e2a-4c9a-4cb9-beb7-91e3ebbd1580",
            "instanceType": "StudyIdentifier"
          },
          {
            "id": "6c694146-2d8d-4a20-834a-845eb7fb65d8",
            "text": "119006",
            "scopeId": "599a1e2a-4c9a-4cb9-beb7-91e3ebbd1580",
            "instanceType": "StudyIdentifier"
          },
          {
            "id": "b52dd52c-9c3a-46c4-8cad-819b28992d87",
            "text": "NCT04573309",
            "scopeId": "599a1e2a-4c9a-4cb9-beb7-91e3ebbd1580",
            "instanceType": "StudyIdentifier"
          }
        ],
        "studyPhase": {
          "id": "3888f565-530d-43d6-894c-321c6a4fd2e9",
          "code": "Phase2",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase2",
          "instanceType": "Code"
        },
        "rationale": "Protocol version"
      }
    ],
    "organizations": [
      {
        "id": "05d44679-da4e-4a4b-a033-cb6068cdfac7",
        "name": "Alexion Pharmaceuticals, Inc.",
        "type": {
          "id": "03475da0-4108-4e1d-8a5f-63e72dddf70d",
          "code": "Pharmaceutical Company",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Pharmaceutical Company",
          "instanceType": "Code"
        },
        "instanceType": "Organization"
      }
    ],
    "indications": [
      {
        "id": "def5da81-4b8d-413b-aff5-4e21ff760bba",
        "name": "Wilson Disease",
        "isRareDisease": false,
        "instanceType": "Indication",
        "description": "Participants with Wilson Disease"
      }
    ],
    "name": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840"
  },
  "administrableProducts": [
    {
      "id": "05d9a79b-91ac-47e9-84a0-2c1483b383fd",
      "name": "ALXN1840 tablets",
      "instanceType": "AdministrableProduct",
      "doseForm": {
        "id": "b6f981fe-3cf3-438f-b1ee-93d134ad6c04",
        "code": "Tablet",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Tablet",
        "instanceType": "Code"
      },
      "strength": "15 mg ALXN1840 containing 7.8 mg tetrathiomolybdic acid",
      "substanceIds": [
        "3c74154d-3e04-4dee-88ba-a4e17fbb222d"
      ],
      "manufacturer": "Alexion"
    }
  ],
  "administrations": [
    {
      "id": "19a045ef-d049-4d61-ab8c-316371962c1e",
      "name": "ALXN1840 15 mg once daily, Days 1–28",
      "instanceType": "Administration",
      "dose": "15 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "c3adf831-7b3e-4540-b56a-aad327e5dea5",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Day 1 through Day 28"
    },
    {
      "id": "ad9dcf47-c788-4605-918d-8ceb5554ef4f",
      "name": "ALXN1840 30 mg once daily, Days 29–39",
      "instanceType": "Administration",
      "dose": "30 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "74e3c8e3-47c0-4e20-83b7-cfae94811e53",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Day 29 through Day 39"
    },
    {
      "id": "18a2876d-d410-47b6-8b26-6337a396e4f1",
      "name": "ALXN1840 15 mg once daily maintained beyond 4 weeks",
      "instanceType": "Administration",
      "dose": "15 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "ccd6634b-44a5-4919-ab09-c5cc9fb61c06",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Up to Day 39 if escalation to 30 mg is not performed for safety reasons"
    },
    {
      "id": "414f207d-bc56-47c2-8289-63058b690c4c",
      "name": "ALXN1840 reduced dosing to 15 mg every other day (dose modification)",
      "instanceType": "Administration",
      "dose": "15 mg",
      "doseFrequency": "every other day",
      "route": {
        "id": "b767818b-0d24-4266-af31-a515e089f3fe",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "As needed per dose modification criteria"
    },
    {
      "id": "dff1cca2-81c5-4064-ab06-80ca725c5c64",
      "name": "ALXN1840 temporary interruption",
      "instanceType": "Administration",
      "dose": "0 mg (hold treatment)",
      "doseFrequency": "N/A",
      "route": {
        "id": "243952cf-3644-4c60-983c-5f420ffb46d9",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Until laboratory/safety parameters improve per protocol criteria"
    },
    {
      "id": "b126a3d0-3f2d-4e97-907d-193e0e7c4f86",
      "name": "ALXN1840 outpatient dosing",
      "instanceType": "Administration",
      "dose": "15 mg or 30 mg according to assigned dose",
      "doseFrequency": "once daily",
      "route": {
        "id": "5249cc9e-fdfb-4380-adc3-15c7eb72cd3b",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Outpatient Period between Day 9 and Day 23 (may be extended up to an additional 14 days)"
    }
  ],
  "substances": [
    {
      "id": "3c74154d-3e04-4dee-88ba-a4e17fbb222d",
      "name": "bis-choline tetrathiomolybdate",
      "instanceType": "Substance",
      "description": "Active pharmaceutical ingredient in ALXN1840; a copper-binding agent also referred to as tetrathiomolybdate"
    },
    {
      "id": "2039510c-d831-4fe4-ad06-6083ff56a662",
      "name": "tetrathiomolybdic acid",
      "instanceType": "Substance",
      "description": "Acid form providing the active anion tetrathiomolybdate in ALXN1840 tablets"
    },
    {
      "id": "75dc5a27-5018-4ead-b817-7f2d010b78e3",
      "name": "tetrathiomolybdate",
      "instanceType": "Substance",
      "description": "Active anion of ALXN1840 responsible for copper binding and decoppering effects"
    }
  ],
  "narrativeContents": [
    {
      "id": "c8c92787-205f-4a55-a752-ab434e4ad1ae",
      "name": "TITLE PAGE",
      "order": 0,
      "instanceType": "NarrativeContent",
      "sectionNumber": "TITLE PAGE",
      "sectionTitle": "TITLE PAGE",
      "sectionType": {
        "id": "4ed1525d-f0a6-4a5d-8d22-b4fdf7a618a2",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "b600014c-0cb5-44d3-a9cc-4747d7589c3e",
      "name": "INVESTIGATOR’S AGREEMENT",
      "order": 1,
      "instanceType": "NarrativeContent",
      "sectionNumber": "INVESTIGATOR’S AGREEMENT",
      "sectionTitle": "INVESTIGATOR’S AGREEMENT",
      "sectionType": {
        "id": "43fb9cab-6cd2-4006-9c29-5fd3bf095204",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "c6649f0b-fd51-4ba2-9f5b-940bc30b4d6c",
      "name": "PROTOCOL AMENDMENT SUMMARY OF CHANGES TABLE",
      "order": 2,
      "instanceType": "NarrativeContent",
      "sectionNumber": "PROTOCOL AMENDMENT SUMMARY OF CHANGES TABLE",
      "sectionTitle": "PROTOCOL AMENDMENT SUMMARY OF CHANGES TABLE",
      "sectionType": {
        "id": "cba729c1-2247-4e7c-9ce7-ab5a38ddb134",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "d71e486a-7988-4b35-8916-5976d83574f1",
      "name": "TABLE OF CONTENTS",
      "order": 3,
      "instanceType": "NarrativeContent",
      "sectionNumber": "TABLE OF CONTENTS",
      "sectionTitle": "TABLE OF CONTENTS",
      "sectionType": {
        "id": "861b6d28-d4b0-4bfb-81eb-12585b354683",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "a6716a76-fec8-4eb3-af96-12fad2896d85",
      "name": "LIST OF TABLES",
      "order": 4,
      "instanceType": "NarrativeContent",
      "sectionNumber": "LIST OF TABLES",
      "sectionTitle": "LIST OF TABLES",
      "sectionType": {
        "id": "00a3828c-2610-426b-b05e-defe5cd2f691",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "0078cc05-5d7c-4843-882d-03858b85fce6",
      "name": "LIST OF FIGURES",
      "order": 5,
      "instanceType": "NarrativeContent",
      "sectionNumber": "LIST OF FIGURES",
      "sectionTitle": "LIST OF FIGURES",
      "sectionType": {
        "id": "794e814a-2055-4093-82f0-68b915d72575",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "2befe116-380c-47b9-a189-961c7fcf1921",
      "name": "PROTOCOL SUMMARY",
      "order": 6,
      "instanceType": "NarrativeContent",
      "sectionNumber": "1",
      "sectionTitle": "PROTOCOL SUMMARY",
      "sectionType": {
        "id": "02d35d42-2972-4feb-9845-73499bfe3401",
        "code": "Synopsis",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Synopsis",
        "instanceType": "Code"
      },
      "childIds": [
        "955a0349-52fd-461c-b489-6ec4e27c4cdb",
        "66538e49-efbf-4a9e-88ca-82ebd6f67509",
        "4a2cdb06-340a-4d76-95aa-2d16d4ea2551"
      ]
    },
    {
      "id": "0e90f759-abc2-4b90-838d-f447feb4abd1",
      "name": "INTRODUCTION",
      "order": 7,
      "instanceType": "NarrativeContent",
      "sectionNumber": "2",
      "sectionTitle": "INTRODUCTION",
      "sectionType": {
        "id": "05067cea-f8ea-43d9-90a7-eee8e3ca9cfc",
        "code": "Introduction",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Introduction",
        "instanceType": "Code"
      },
      "childIds": [
        "8b15b60f-ccbb-42c2-8194-c9aa461ff397",
        "aa40ca97-e196-45f0-819e-e05be41c72a5",
        "7acd5bd3-7be8-4450-9002-f0bb38a68379"
      ]
    },
    {
      "id": "ebddeaa6-c50d-4a0e-abb5-6ad770aa9dce",
      "name": "OBJECTIVES AND ENDPOINTS",
      "order": 8,
      "instanceType": "NarrativeContent",
      "sectionNumber": "3",
      "sectionTitle": "OBJECTIVES AND ENDPOINTS",
      "sectionType": {
        "id": "233b7ce3-909e-40a1-8029-2290e7c945cd",
        "code": "Objectives",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Objectives",
        "instanceType": "Code"
      }
    },
    {
      "id": "83450b76-27c9-43b2-8b8a-a7937b6bc73a",
      "name": "STUDY DESIGN",
      "order": 9,
      "instanceType": "NarrativeContent",
      "sectionNumber": "4",
      "sectionTitle": "STUDY DESIGN",
      "sectionType": {
        "id": "c38bb358-484a-4a04-a818-aa1d0a1bc6ee",
        "code": "Study Design",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Study Design",
        "instanceType": "Code"
      },
      "childIds": [
        "48106787-cd73-411e-82bf-62421f7af550",
        "6f5b2d68-650a-4edc-90c4-8e8f3b244352",
        "e61074d7-fa19-4b7e-83a6-b6a5cfdbabec",
        "37fa018c-398e-4e6c-a070-be9cdd89b478"
      ]
    },
    {
      "id": "64b28f2e-509d-4446-84ba-2698af9e0c1a",
      "name": "STUDY POPULATION",
      "order": 10,
      "instanceType": "NarrativeContent",
      "sectionNumber": "5",
      "sectionTitle": "STUDY POPULATION",
      "sectionType": {
        "id": "15715764-fbce-439c-b5e4-9cb9f3d6fd1a",
        "code": "Study Population",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Study Population",
        "instanceType": "Code"
      },
      "childIds": [
        "9deffc9f-91e3-49e0-ad32-3ac6aec5286e",
        "c0eed583-8063-4cf9-be6c-395cdc7acdd1",
        "2dbce34c-03ae-43a4-9111-10825942598f",
        "d05ce7c3-38b8-427f-8e8d-b3140331ac70"
      ]
    },
    {
      "id": "f111e557-ad68-4ab6-8d1d-93ab47f1a147",
      "name": "STUDY INTERVENTION",
      "order": 11,
      "instanceType": "NarrativeContent",
      "sectionNumber": "6",
      "sectionTitle": "STUDY INTERVENTION",
      "sectionType": {
        "id": "16377f8d-3617-4e30-8894-a19845e9deb2",
        "code": "Treatment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Treatment",
        "instanceType": "Code"
      }
    },
    {
      "id": "3da47894-0638-486c-942e-84fc65c0ed38",
      "name": "Study and Site Start and Closure",
      "order": 12,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10.1.8",
      "sectionTitle": "Study and Site Start and Closure",
      "sectionType": {
        "id": "8c15279a-fdb1-44f5-a301-d26c212019aa",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "dcfa9ce8-b3f2-46fc-af6e-aef0c8c3413a",
      "name": "Publication Policy",
      "order": 13,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10.1.9",
      "sectionTitle": "Publication Policy",
      "sectionType": {
        "id": "de136e4a-2fe9-4852-955c-60680b3a761a",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "62de1314-a44e-47c8-921a-2f3a9706fa86",
      "name": "Clinical Laboratory Tests",
      "order": 14,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10.2",
      "sectionTitle": "Clinical Laboratory Tests",
      "sectionType": {
        "id": "36dd28b5-3dc1-40cf-8e4f-f4915ac3fab8",
        "code": "Assessments",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessments",
        "instanceType": "Code"
      }
    },
    {
      "id": "3552363e-f806-4ae7-afa6-b3f07f8ce189",
      "name": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
      "order": 15,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10.3",
      "sectionTitle": "Adverse Events: Definitions and Procedures for Recording, Evaluating, Follow-up, and Reporting",
      "sectionType": {
        "id": "64a973b8-2cf5-46f3-996f-4b8d53023d9d",
        "code": "Safety",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Safety",
        "instanceType": "Code"
      },
      "childIds": [
        "354add64-fca0-406c-bb5c-c0c15f86253a",
        "a307d25a-657d-4684-ae35-0763651cf4a6",
        "d57beeab-ff1c-42ee-aa14-48f31f260c48",
        "ea1bfc6e-9a1b-4fb8-99de-4b74200dbd03"
      ]
    },
    {
      "id": "32f161d3-6400-4854-80a8-d851cebde1ab",
      "name": "Contraceptive Guidance and Collection of Pregnancy Information",
      "order": 16,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10.4",
      "sectionTitle": "Contraceptive Guidance and Collection of Pregnancy Information",
      "sectionType": {
        "id": "539b35ba-ac31-488b-88a7-645dd4ce2672",
        "code": "Safety",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Safety",
        "instanceType": "Code"
      },
      "childIds": [
        "73b66c0f-f8a2-4b0a-a605-e1dce114a9b8",
        "10a88b42-b6c7-40eb-b232-c86a669c7a59"
      ]
    },
    {
      "id": "ffab307d-6d63-4908-a64f-bc76aa3be33c",
      "name": "COVID-19 Vaccine Risk Assessment",
      "order": 17,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10.5",
      "sectionTitle": "COVID-19 Vaccine Risk Assessment",
      "sectionType": {
        "id": "5aa24b24-84f6-444a-9c49-2aa3e94611de",
        "code": "Safety",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Safety",
        "instanceType": "Code"
      }
    },
    {
      "id": "f3afb235-22c6-41bb-993c-8e96b5bda13d",
      "name": "Abbreviations",
      "order": 18,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10.6",
      "sectionTitle": "Abbreviations",
      "sectionType": {
        "id": "4a61ad5a-ec3f-4ab1-b675-a48542a55347",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "4d969a31-0b79-4a97-8be9-cad24c093587",
      "name": "Protocol Amendment History",
      "order": 19,
      "instanceType": "NarrativeContent",
      "sectionNumber": "10.7",
      "sectionTitle": "Protocol Amendment History",
      "sectionType": {
        "id": "a045141d-8ae6-4519-aaf2-cf2ca41027f4",
        "code": "Other",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other",
        "instanceType": "Code"
      }
    },
    {
      "id": "08700871-e020-44d0-bc4b-bd9331f2637f",
      "name": "REFERENCES",
      "order": 20,
      "instanceType": "NarrativeContent",
      "sectionNumber": "11",
      "sectionTitle": "REFERENCES",
      "sectionType": {
        "id": "4f4d3301-4eff-43b2-86ff-662532717754",
        "code": "References",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "References",
        "instanceType": "Code"
      }
    }
  ],
  "abbreviations": [
    {
      "id": "4a3cbc6e-c3d2-43d9-a876-91fc58c674d5",
      "abbreviatedText": "ADME",
      "expandedText": "absorption, distribution, metabolism, and excretion",
      "instanceType": "Abbreviation"
    },
    {
      "id": "38d409d3-a073-4c68-be61-a13e514aab91",
      "abbreviatedText": "AE",
      "expandedText": "Adverse Event",
      "instanceType": "Abbreviation"
    },
    {
      "id": "d8ba7543-c9d1-4985-97b1-957287f35f7f",
      "abbreviatedText": "ALXN1840",
      "expandedText": "ALXN1840",
      "instanceType": "Abbreviation"
    },
    {
      "id": "8b8b3a96-c332-4e56-8a8f-49428cc4b5ca",
      "abbreviatedText": "BP",
      "expandedText": "Blood Pressure",
      "instanceType": "Abbreviation"
    },
    {
      "id": "c18e75c5-8a5c-417d-a569-a6abda6fa900",
      "abbreviatedText": "COVID-19",
      "expandedText": "Coronavirus Disease 2019",
      "instanceType": "Abbreviation"
    },
    {
      "id": "a6125fd6-4279-4f1e-9f23-9baa32ed4eb4",
      "abbreviatedText": "ECG",
      "expandedText": "Electrocardiogram",
      "instanceType": "Abbreviation"
    },
    {
      "id": "12d62de6-0a81-4fdc-917e-73c9156ab14f",
      "abbreviatedText": "HbA1c",
      "expandedText": "Glycated Hemoglobin",
      "instanceType": "Abbreviation"
    },
    {
      "id": "dfffc797-3a9e-42b9-9e38-5fd316e1993d",
      "abbreviatedText": "HR",
      "expandedText": "Heart Rate",
      "instanceType": "Abbreviation"
    },
    {
      "id": "cf79f776-060f-4377-8c48-99b06af0f8b5",
      "abbreviatedText": "ICF",
      "expandedText": "Informed Consent Form",
      "instanceType": "Abbreviation"
    },
    {
      "id": "10c38abf-81b9-49bb-9b18-98d5d03fc2ef",
      "abbreviatedText": "NCC",
      "expandedText": "non-ceruloplasmin-bound copper",
      "instanceType": "Abbreviation"
    },
    {
      "id": "1b78babe-a2b6-4d5e-bf7c-ffedff2edb18",
      "abbreviatedText": "NCCcorrected",
      "expandedText": "non-ceruloplasmin-bound copper corrected for the stable tetrathiomolybdate- copper -albumin tripartite complex",
      "instanceType": "Abbreviation"
    },
    {
      "id": "7ade6d18-7bac-46f1-8aa9-6d8b9d3bf3dd",
      "abbreviatedText": "PK",
      "expandedText": "pharmacokinetics",
      "instanceType": "Abbreviation"
    },
    {
      "id": "662706d6-29fd-498f-9375-5407800c06cf",
      "abbreviatedText": "SAE",
      "expandedText": "Serious Adverse Event",
      "instanceType": "Abbreviation"
    },
    {
      "id": "66220c5b-e34b-4f57-942a-007c193af86e",
      "abbreviatedText": "SARS-CoV-2",
      "expandedText": "Severe Acute Respiratory Syndrome Coronavirus 2",
      "instanceType": "Abbreviation"
    },
    {
      "id": "6b37d729-4b9e-4d91-bb18-b54abf0366e9",
      "abbreviatedText": "SoA",
      "expandedText": "Schedule of Activities",
      "instanceType": "Abbreviation"
    },
    {
      "id": "7a99ff5f-d594-494a-b8cc-f6337c555531",
      "abbreviatedText": "TPC",
      "expandedText": "tetrathiomolybdate- copper -albumin tripartite complex",
      "instanceType": "Abbreviation"
    },
    {
      "id": "eac3eebf-26ce-42c7-a6c5-4c998dce1495",
      "abbreviatedText": "US",
      "expandedText": "United States",
      "instanceType": "Abbreviation"
    },
    {
      "id": "a28a984e-4ef2-4ed9-a6b5-7e81fac35604",
      "abbreviatedText": "WD",
      "expandedText": "Wilson disease",
      "instanceType": "Abbreviation"
    }
  ],
  "studyDefinitionDocument": {
    "id": "961e3e70-673e-44ba-9239-2552b8e4ef0c",
    "name": "A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants with Wilson Disease Treated with ALXN1840",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "Amendment 3.1 (US)",
    "versionDate": "2022-03-18",
    "contentIds": [
      "c8c92787-205f-4a55-a752-ab434e4ad1ae",
      "b600014c-0cb5-44d3-a9cc-4747d7589c3e",
      "c6649f0b-fd51-4ba2-9f5b-940bc30b4d6c",
      "d71e486a-7988-4b35-8916-5976d83574f1",
      "a6716a76-fec8-4eb3-af96-12fad2896d85",
      "0078cc05-5d7c-4843-882d-03858b85fce6",
      "2befe116-380c-47b9-a189-961c7fcf1921",
      "0e90f759-abc2-4b90-838d-f447feb4abd1",
      "ebddeaa6-c50d-4a0e-abb5-6ad770aa9dce",
      "83450b76-27c9-43b2-8b8a-a7937b6bc73a",
      "64b28f2e-509d-4446-84ba-2698af9e0c1a",
      "f111e557-ad68-4ab6-8d1d-93ab47f1a147",
      "3da47894-0638-486c-942e-84fc65c0ed38",
      "dcfa9ce8-b3f2-46fc-af6e-aef0c8c3413a",
      "62de1314-a44e-47c8-921a-2f3a9706fa86",
      "3552363e-f806-4ae7-afa6-b3f07f8ce189",
      "32f161d3-6400-4854-80a8-d851cebde1ab",
      "ffab307d-6d63-4908-a64f-bc76aa3be33c",
      "f3afb235-22c6-41bb-993c-8e96b5bda13d",
      "4d969a31-0b79-4a97-8be9-cad24c093587",
      "08700871-e020-44d0-bc4b-bd9331f2637f"
    ]
  },
  "studyAmendments": [
    {
      "id": "aea4cb74-212c-46e4-b6a0-f22a324c359a",
      "number": "1",
      "scope": {
        "id": "df5d94ff-602f-4a41-967d-48ccd753b4ea",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The main reason for preparation of this amendment was to update procedures outlined in the Schedule of Activities, remove contradictory text on the reporting of serious adverse events, and add details of an interim analysis. Additional, minor changes are included in the table below.",
      "effectiveDate": "2020-08-18",
      "reasonIds": [
        "01482876-f7d2-4883-945d-0d206be38cfe",
        "7f06f6c9-2cea-4682-822f-c499f92c2b2f",
        "d19e613d-a82d-4471-8fd4-85d3b45ef42a",
        "ec510bc9-10ab-4b9c-94e9-d4a2d8e3df5b"
      ],
      "previousVersion": "Original Protocol",
      "newVersion": "1"
    },
    {
      "id": "4ac16fc8-0ae2-4f33-84cd-d55a6cf3492a",
      "number": "2",
      "scope": {
        "id": "97cdcb87-4c29-4ff1-82f1-6272284a9728",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The main reason for preparation of this amendment was to revise the exclusion criterion for a urine drug screen. Changes implemented via Administrative Letter 1 and Administrative Letter 2, as well as COVID vaccination guidance, have also been incorporated.",
      "effectiveDate": "2021-03-19",
      "reasonIds": [
        "c1058b01-facf-4b81-9392-42a8277d4b41",
        "81ba30ff-b635-4a1a-ae54-166e63f04408",
        "42a26101-e9a0-4ffc-a395-892a20613ff4",
        "732f4ae3-bd77-447e-a87b-5f9380741647"
      ],
      "previousVersion": "1",
      "newVersion": "2"
    },
    {
      "id": "5e170a09-ff6b-453f-b829-8df9066759cd",
      "number": "3",
      "scope": {
        "id": "b2f1ff30-a9c8-4a96-b040-e1a9677b06ae",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The main reason for preparation of this amendment was to update the washout period for zinc. Additional changes are listed below.",
      "effectiveDate": "2021-08-31",
      "reasonIds": [
        "242cd9ad-1267-4bfc-8de8-a9487fc5725b",
        "22248fc3-3b6b-46de-baa4-d26636406700",
        "b4312693-6db3-4a65-8efe-677ba096e071"
      ],
      "previousVersion": "2",
      "newVersion": "3"
    },
    {
      "id": "693f39c8-e268-4178-9013-67a412afa986",
      "number": "3.1 (US)",
      "scope": {
        "id": "6f062b34-7e0c-4def-9f4b-598bab651340",
        "code": "Global",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Global",
        "instanceType": "Code"
      },
      "instanceType": "StudyAmendment",
      "summary": "The main reason for preparation of this amendment was to clarify study procedures occurring across different sites in the US, so as to facilitate participant recruitment across different regions of the US, and to lessen inconvenience for participants without compromising the quality of the study.",
      "effectiveDate": "2022-03-18",
      "reasonIds": [
        "efc1c8bd-430e-4093-b03f-2c195bc2b072",
        "89405d77-42f1-4348-b67d-0e619d9ae580"
      ],
      "previousVersion": "3",
      "newVersion": "3.1 (US)"
    }
  ],
  "geographicScope": {
    "id": "f3b45d9b-28a4-4196-9732-948f03e9323a",
    "name": "Study Geographic Scope",
    "scopeType": "Multinational",
    "instanceType": "GeographicScope",
    "countryIds": [
      "e8a79682-f44c-4230-85f9-2814430a759a",
      "505af665-94a1-4357-b80e-66550eb5e82c"
    ],
    "regions": [
      "North America",
      "Europe"
    ]
  },
  "countries": [
    {
      "id": "e8a79682-f44c-4230-85f9-2814430a759a",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    },
    {
      "id": "505af665-94a1-4357-b80e-66550eb5e82c",
      "name": "United Kingdom",
      "instanceType": "Country",
      "code": "GB"
    }
  ],
  "procedures": [
    {
      "id": "388a1735-9ed2-4e13-8561-674c8c2ff4fe",
      "name": "Informed consent",
      "instanceType": "Procedure",
      "label": "Informed consent process",
      "description": "Process of obtaining written informed consent from the participant prior to any study-specific procedures",
      "procedureType": {
        "id": "0321dfbf-01a2-427f-bd62-db17248e431c",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "b1cdc020-fc93-4beb-b4cc-6a02a3fc89e9",
        "code": "V65.49",
        "codeSystem": "ICD-9-CM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Other specified counseling",
        "instanceType": "Code"
      }
    },
    {
      "id": "259e8356-5c63-4e11-9a8d-dff79f6cc68c",
      "name": "Medical history and demographics",
      "instanceType": "Procedure",
      "label": "Medical history/demographics",
      "description": "Collection of participant medical history, Wilson disease history, prior WD treatment, and demographic data",
      "procedureType": {
        "id": "8d211410-8276-43c7-9a28-1ca38f73aac7",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "3118c29c-6936-4610-833d-1b598045dc08",
        "code": "99201",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Office or other outpatient visit, new patient, problem focused",
        "instanceType": "Code"
      }
    },
    {
      "id": "4e16a125-3b8a-4bf6-a34f-37c48f47f9d3",
      "name": "Physical examination",
      "instanceType": "Procedure",
      "label": "Full physical examination",
      "description": "Complete physical examination including cardiovascular, respiratory, gastrointestinal, and neurological systems, with symptom-driven exams as needed",
      "procedureType": {
        "id": "81db15e9-02de-4c54-ae29-f9bd2ec2b237",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "5bcf0728-6189-4b6e-ad14-c1eeaf98cb65",
        "code": "99385",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Initial comprehensive preventive medicine evaluation and management",
        "instanceType": "Code"
      }
    },
    {
      "id": "febdf9fa-4ec7-4fd3-94d5-b4dc843aae4e",
      "name": "Height and weight measurement",
      "instanceType": "Procedure",
      "label": "Height, weight, and BMI",
      "description": "Measurement of body height, body weight and calculation of body mass index",
      "procedureType": {
        "id": "1add85f2-7eb7-4a43-a5c9-5af64f9f350a",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "81c6bbb6-341b-4813-ba16-2481c668bbc5",
        "code": "3008F",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Body mass index documented",
        "instanceType": "Code"
      }
    },
    {
      "id": "c0d287ad-f053-4a43-bd43-a02e70099c7e",
      "name": "Vital signs measurement",
      "instanceType": "Procedure",
      "label": "Vital signs",
      "description": "Measurement of body temperature, heart rate, respiratory rate, and systolic and diastolic blood pressure using automated device when available",
      "procedureType": {
        "id": "3afb5963-782a-4111-a28c-7d2384c48236",
        "code": "Monitoring",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring",
        "instanceType": "Code"
      },
      "code": {
        "id": "f284182f-f6ad-458a-b552-f0ea256bded5",
        "code": "99473",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Self-measured blood pressure using a device validated for clinical accuracy; patient education/training",
        "instanceType": "Code"
      }
    },
    {
      "id": "0fe2bcf8-9689-4083-93d3-e389d5da6666",
      "name": "12-lead electrocardiogram",
      "instanceType": "Procedure",
      "label": "Triplicate 12-lead ECG",
      "description": "Triplicate 12-lead ECGs including heart rate and PR, QRS, QT, and QTc intervals; collected at specified time points including 4 hours postdose on certain days",
      "procedureType": {
        "id": "902d8b6e-9efc-4bd8-b80d-89853d867924",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "601a4f23-49f6-40b0-9ae3-10c59e821348",
        "code": "93005",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Electrocardiogram, routine ECG with at least 12 leads; tracing only",
        "instanceType": "Code"
      }
    },
    {
      "id": "7c9f3e53-4f61-468d-bd05-0bdffcac8f4c",
      "name": "Blood draw for pharmacokinetics and pharmacodynamics",
      "instanceType": "Procedure",
      "label": "Blood sampling for PK/PD",
      "description": "Venous blood sampling for measurement of plasma total molybdenum, plasma ultrafiltrate molybdenum, plasma total and ultrafiltrate copper, labile bound copper, ceruloplasmin, and ceruloplasmin-bound copper at specified time points",
      "procedureType": {
        "id": "ae9e5d86-1ab3-4d30-baba-a68e997f5b9e",
        "code": "Sample Collection",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Sample Collection",
        "instanceType": "Code"
      },
      "code": {
        "id": "596dc0ff-b4cc-4267-b060-a1eea82f6b76",
        "code": "36415",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Collection of venous blood by venipuncture",
        "instanceType": "Code"
      }
    },
    {
      "id": "4c14ad34-e663-4496-b38b-a94e9364140d",
      "name": "Retained serum sample collection",
      "instanceType": "Procedure",
      "label": "Retained serum sample (safety)",
      "description": "Collection of a single 15 mL serum sample for potential future analysis in the event of unexpected safety findings",
      "procedureType": {
        "id": "3ad7a4a0-38b1-4507-993e-5d680dc969ac",
        "code": "Sample Collection",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Sample Collection",
        "instanceType": "Code"
      },
      "code": {
        "id": "f5cba073-c2f9-45e7-a21d-73ecbd461fff",
        "code": "36415",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Collection of venous blood by venipuncture",
        "instanceType": "Code"
      }
    },
    {
      "id": "e64c4c01-500e-4901-a40d-cdcc0337ec1f",
      "name": "Clinical chemistry testing",
      "instanceType": "Procedure",
      "label": "Serum chemistry",
      "description": "Laboratory serum chemistry testing following at least 8 hours fasting at screening and check-in, and at specified on-treatment time points",
      "procedureType": {
        "id": "a444dbd1-c3d2-4c27-b4ee-86a3f84d76fa",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "dd08f292-326f-4907-95cd-fc90b834f6bb",
        "code": "80053",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Comprehensive metabolic panel",
        "instanceType": "Code"
      }
    },
    {
      "id": "2d4d5cd8-38ba-48f0-80a2-931ed24d1870",
      "name": "Hematology testing",
      "instanceType": "Procedure",
      "label": "Hematology",
      "description": "Complete blood count testing including monitoring for anemia and leukopenia",
      "procedureType": {
        "id": "bfcd336a-410c-44a0-b90a-0c24d7f8a0ce",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "84956d9f-49a3-4e62-bc60-01bc3b3d0dce",
        "code": "85025",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Complete blood count (CBC) with automated differential",
        "instanceType": "Code"
      }
    },
    {
      "id": "1b9a41f4-306c-4e0e-9ce3-c9020804799e",
      "name": "Coagulation testing",
      "instanceType": "Procedure",
      "label": "Coagulation tests",
      "description": "Laboratory assessment of coagulation parameters at specified time points",
      "procedureType": {
        "id": "318cca6d-04ae-45b4-9f1a-0937f32e35b6",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "00f35dc0-e8f4-48d5-b46c-89751cf5c32a",
        "code": "85730",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Thromboplastin time, partial (PTT); plasma",
        "instanceType": "Code"
      }
    },
    {
      "id": "665558b3-045d-4f60-8e3f-a84e0eeefb5b",
      "name": "Urinalysis",
      "instanceType": "Procedure",
      "label": "Urinalysis",
      "description": "Routine urinalysis performed at screening and during the study",
      "procedureType": {
        "id": "63992f4c-b136-40c3-9f6f-07b3df28c2d0",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "16b0637a-0c13-4407-ae1f-85f047256f9d",
        "code": "81001",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Urinalysis, automated, with microscopy",
        "instanceType": "Code"
      }
    },
    {
      "id": "acd4c180-c89d-4fab-9ac8-f66c40779ea7",
      "name": "Serum pregnancy test",
      "instanceType": "Procedure",
      "label": "Serum pregnancy test",
      "description": "Serum pregnancy testing for women of childbearing potential at screening and as required by site policies",
      "procedureType": {
        "id": "7faeb311-884f-4d87-a33c-8415cdbbd679",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "679f2674-8e3b-4b21-8f3c-458413e380a1",
        "code": "84702",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Chorionic gonadotropin test, quantitative",
        "instanceType": "Code"
      }
    },
    {
      "id": "d1fca262-ed53-4eb8-a687-6be3afce5a42",
      "name": "Urine pregnancy test",
      "instanceType": "Procedure",
      "label": "Urine pregnancy test",
      "description": "Urine pregnancy testing at protocol-specified visits and at least every 4 weeks during the study for women of childbearing potential",
      "procedureType": {
        "id": "8ee1b71d-c464-449c-a8fa-c837e48b006a",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "48094d83-0e84-40f6-90e0-80f810f789ac",
        "code": "81025",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Urine pregnancy test, by visual color comparison methods",
        "instanceType": "Code"
      }
    },
    {
      "id": "f3b31fd0-b122-416e-94e9-0755dfdd17ea",
      "name": "Follicle-stimulating hormone test",
      "instanceType": "Procedure",
      "label": "FSH test (post-menopausal females)",
      "description": "Measurement of follicle-stimulating hormone in post-menopausal females when needed to confirm menopause",
      "procedureType": {
        "id": "3a571e03-d759-4b3b-bcdb-89be418900cc",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "cfb57c41-7c4f-40d7-9d3f-baa3139ad72b",
        "code": "83001",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Gonadotropin, follicle stimulating hormone (FSH); serum",
        "instanceType": "Code"
      }
    },
    {
      "id": "ad9b8d09-a493-4c6e-b1da-008b811d3aaa",
      "name": "Alcohol test",
      "instanceType": "Procedure",
      "label": "Alcohol test",
      "description": "Testing for alcohol use at screening and check-in",
      "procedureType": {
        "id": "613b47cd-f0a6-446e-9a73-6cfb770e51a5",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "4047f658-2bff-4483-bb4d-5064fdd1e50f",
        "code": "82055",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Alcohol (ethanol); any specimen except breath",
        "instanceType": "Code"
      }
    },
    {
      "id": "953b0a92-7752-4923-b975-a717db8a861b",
      "name": "Urine drug screen",
      "instanceType": "Procedure",
      "label": "Urine drug screen",
      "description": "Urine testing for drugs of abuse at screening and check-in",
      "procedureType": {
        "id": "0cfd7f4d-3617-41e3-a648-c55ca7d337c5",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "63a338ed-a0af-4da4-9372-392ae87eb574",
        "code": "80307",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Drug test(s), presumptive, any number of drug classes",
        "instanceType": "Code"
      }
    },
    {
      "id": "ddd02a6e-f078-4d06-a5b9-38619baac56f",
      "name": "HIV, hepatitis B and C screening",
      "instanceType": "Procedure",
      "label": "Viral infection screening",
      "description": "Laboratory screening tests for HIV, hepatitis B, and hepatitis C infection",
      "procedureType": {
        "id": "bbe46460-5476-4f34-a93d-eacde5487d84",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "90f8d084-d10f-4803-9c63-8c84d1d9a085",
        "code": "80074",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Acute hepatitis panel",
        "instanceType": "Code"
      }
    },
    {
      "id": "677d2027-cd5a-4d9e-b8d0-e8eb8946f553",
      "name": "Copper and molybdenum mass balance assessment",
      "instanceType": "Procedure",
      "label": "Copper and molybdenum balance measurements",
      "description": "Assessment of net copper and molybdenum balance based on intake and output, using ICP-MS analysis of all intake and excreta",
      "procedureType": {
        "id": "8a14fc7d-ea6b-4c9b-b21a-492b0d9e3f92",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "20ef5089-e696-4dec-8012-ba6f3c39eb2b",
        "code": "82525",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Copper; serum",
        "instanceType": "Code"
      }
    },
    {
      "id": "2b75442c-9ac5-4085-8e63-03f235630196",
      "name": "Food and fluid sampling",
      "instanceType": "Procedure",
      "label": "Food and fluid collection for Cu/Mo concentrations",
      "description": "Collection of samples from all meal and fluid batches, including water from a common dispenser, for copper and molybdenum concentration analysis by ICP-MS",
      "procedureType": {
        "id": "0397b7f5-88a8-4a3b-91fd-e20bcd3c982e",
        "code": "Sample Collection",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Sample Collection",
        "instanceType": "Code"
      },
      "code": {
        "id": "65f67235-e4d4-4fa8-a466-437fad6d3ceb",
        "code": "99001",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Handling and/or conveyance of specimen for transfer",
        "instanceType": "Code"
      }
    },
    {
      "id": "4b484822-9bdf-4d03-abe3-724460d42a46",
      "name": "24-hour urine collection",
      "instanceType": "Procedure",
      "label": "24-hour urine for copper and molybdenum",
      "description": "Collection of 24-hour pooled urine samples for measurement of copper and molybdenum content and volume recording",
      "procedureType": {
        "id": "5338cba3-ecb6-452e-a9b1-90cdea92c2b1",
        "code": "Sample Collection",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Sample Collection",
        "instanceType": "Code"
      },
      "code": {
        "id": "6ab18496-8544-400a-a976-a43385967128",
        "code": "81050",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Urinalysis, 24-hour collection",
        "instanceType": "Code"
      }
    },
    {
      "id": "b8e7206d-ed5f-4e39-9559-947c9989c8d6",
      "name": "Fecal sample collection",
      "instanceType": "Procedure",
      "label": "Feces for copper and molybdenum",
      "description": "Individual collection, weighing, and time-stamping of each stool sample for copper and molybdenum concentration analysis by ICP-MS",
      "procedureType": {
        "id": "323c71d1-ac46-48ad-a279-cdd2b1f4a3c1",
        "code": "Sample Collection",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Sample Collection",
        "instanceType": "Code"
      },
      "code": {
        "id": "8ed70c50-4121-462f-ba3f-b83c0aee5486",
        "code": "83993",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Specialty fecal analysis, not otherwise specified",
        "instanceType": "Code"
      }
    },
    {
      "id": "aa154f23-a61d-4808-8018-a324c1650666",
      "name": "Urination and bowel movement monitoring",
      "instanceType": "Procedure",
      "label": "Bowel and urine monitoring",
      "description": "Monitoring and recording of urination and bowel movements, including weight and time of bowel movements and menstruation checks for women",
      "procedureType": {
        "id": "7dff4c07-68cb-46a8-932f-fa63b6b7625d",
        "code": "Monitoring",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring",
        "instanceType": "Code"
      },
      "code": {
        "id": "c4ae993d-8f2c-4896-bd89-2bc423349084",
        "code": "99457",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Remote physiologic monitoring treatment management services, 20 minutes or more",
        "instanceType": "Code"
      }
    },
    {
      "id": "97f19a64-8525-4f0a-8209-c4f06f5a32d9",
      "name": "Intake monitoring",
      "instanceType": "Procedure",
      "label": "Food and fluid intake monitoring",
      "description": "Monitoring of intake of investigational agent, food, and fluids as part of balance assessments",
      "procedureType": {
        "id": "a4573399-5c1c-40e4-8566-b645825508c2",
        "code": "Monitoring",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring",
        "instanceType": "Code"
      },
      "code": {
        "id": "cfc32555-d4e0-4199-88ff-85094441570a",
        "code": "97802",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Medical nutrition therapy; initial assessment and intervention",
        "instanceType": "Code"
      }
    },
    {
      "id": "585bc114-ebca-45a6-a668-7781f5dfa224",
      "name": "Copper- and molybdenum-controlled diet administration",
      "instanceType": "Procedure",
      "label": "Cu/Mo-controlled meals",
      "description": "Provision and supervision of copper- and molybdenum-controlled diet during inpatient periods, with encouragement to complete all meals",
      "procedureType": {
        "id": "ee77d068-2b9d-444e-8378-49a1c4af113f",
        "code": "Therapeutic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic",
        "instanceType": "Code"
      },
      "code": {
        "id": "51fd3cbb-dfb4-429f-9715-a784bf512909",
        "code": "97803",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Medical nutrition therapy; re-assessment and intervention",
        "instanceType": "Code"
      }
    },
    {
      "id": "a5d113ee-1676-47d4-b92a-119ea6f499ae",
      "name": "Light exercise program",
      "instanceType": "Procedure",
      "label": "Light exercise regimen",
      "description": "Implementation of a light exercise regimen during specified days as part of metabolic monitoring",
      "procedureType": {
        "id": "01bfc5dc-325b-4893-bb12-9b6cfb72b363",
        "code": "Therapeutic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic",
        "instanceType": "Code"
      },
      "code": {
        "id": "a320af8d-4bf6-4760-a914-4075a5eff101",
        "code": "97110",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Therapeutic exercises",
        "instanceType": "Code"
      }
    },
    {
      "id": "7cf79901-3033-4012-bbc7-3b9404698d9b",
      "name": "Adverse event assessment",
      "instanceType": "Procedure",
      "label": "Adverse events monitoring",
      "description": "Ongoing assessment and documentation of treatment-emergent adverse events and serious adverse events throughout the study",
      "procedureType": {
        "id": "2b068328-d4d4-464a-adc9-75824ff30e4c",
        "code": "Monitoring",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring",
        "instanceType": "Code"
      },
      "code": {
        "id": "9e06fd03-bb8f-4cbe-bd4c-43a421919958",
        "code": "99211",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Office or other outpatient visit for the evaluation and management of an established patient",
        "instanceType": "Code"
      }
    },
    {
      "id": "ce070dc6-de9a-4cc1-b467-2f4fdcb8b0ff",
      "name": "Suicidal ideation and behavior risk monitoring",
      "instanceType": "Procedure",
      "label": "Suicidality monitoring",
      "description": "Monitoring participants for suicidal ideation and behavior risk at specified intervals",
      "procedureType": {
        "id": "c66eae06-0cf7-4cea-ae42-10f0fed3b377",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "66ed32a1-a306-41df-8e88-50ecc274468c",
        "code": "96127",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Brief emotional/behavioral assessment",
        "instanceType": "Code"
      }
    },
    {
      "id": "687aaedb-1bbc-496b-a9a0-ec9b56a4da8a",
      "name": "Contraception counseling",
      "instanceType": "Procedure",
      "label": "Discuss/document contraception",
      "description": "Discussion and documentation of contraceptive use and requirements with study participants",
      "procedureType": {
        "id": "08846c16-a34e-477a-80ca-fbd942a3bf07",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "a43c0573-1ea4-42e4-a137-e8b8f60efb95",
        "code": "99401",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Preventive medicine counseling and/or risk factor reduction intervention",
        "instanceType": "Code"
      }
    },
    {
      "id": "0d570e82-0128-411f-828b-1df49d6622b4",
      "name": "Outpatient visit or phone follow-up",
      "instanceType": "Procedure",
      "label": "Outpatient visit or phone call",
      "description": "Outpatient clinic visit or telephone contact for safety laboratory assessment and follow-up",
      "procedureType": {
        "id": "d4b5663f-c0e2-466c-80ee-05c10b1b93ed",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "ab3aeedc-9cfd-4b51-82e9-bbc56a00ef62",
        "code": "99441",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Telephone evaluation and management service",
        "instanceType": "Code"
      }
    },
    {
      "id": "b55dd393-6dde-4cfb-b2d8-e2a5b70994f9",
      "name": "Hospital admission to clinical research unit",
      "instanceType": "Procedure",
      "label": "Admit to unit",
      "description": "Admission of participant to the clinical research unit for inpatient study periods and intensive metabolic monitoring",
      "procedureType": {
        "id": "7a98c6f8-363b-4835-ad31-7fae1126cbf4",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "41955634-7d14-437d-818d-de718a6cf1ed",
        "code": "99221",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Initial hospital care, per day, for the evaluation and management of a patient",
        "instanceType": "Code"
      }
    },
    {
      "id": "e2d55947-42bf-4823-a017-95e06d40f757",
      "name": "Hospital discharge from clinical research unit",
      "instanceType": "Procedure",
      "label": "Discharge from unit",
      "description": "Discharge of participant from the clinical research unit after completion of all required procedures and safety assessment review",
      "procedureType": {
        "id": "160b0168-c11e-4c1d-ae1a-4061433bd79d",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "93df8a95-b0b6-4f2f-9f7c-b9247f27dcfd",
        "code": "99238",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Hospital discharge day management; 30 minutes or less",
        "instanceType": "Code"
      }
    },
    {
      "id": "4a6a1268-8779-4596-a7b3-bc12d9cb1d66",
      "name": "Wilson disease history assessment",
      "instanceType": "Procedure",
      "label": "WD history",
      "description": "Collection of Wilson disease history including diagnosis date, method of diagnosis, history of cirrhosis, prior liver biopsies, and treatments received",
      "procedureType": {
        "id": "b3f5bf00-23a3-4eec-b060-13dcd0c77f06",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "16cbfb3c-0e64-46b4-bee8-8102d764644a",
        "code": "99417",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Prolonged office or other outpatient evaluation and management service",
        "instanceType": "Code"
      }
    },
    {
      "id": "c8f1ca42-b416-458f-a640-ad39086a4e7f",
      "name": "Concomitant medication and therapy review",
      "instanceType": "Procedure",
      "label": "Concomitant medication and therapy review",
      "description": "Recording and evaluation of all concomitant medications and non-pharmacologic therapies or procedures",
      "procedureType": {
        "id": "837dfc8e-40c4-4dc6-80c1-651d82f586b9",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "fc81e8c9-9337-4ba2-a160-957b216c0696",
        "code": "G8427",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient’s current medications",
        "instanceType": "Code"
      }
    },
    {
      "id": "3c07a099-5574-4177-8aa3-9fa4f2381bd1",
      "name": "Copper and molybdenum measurement by ICP-MS",
      "instanceType": "Procedure",
      "label": "ICP-MS analysis",
      "description": "Laboratory determination of copper and molybdenum concentration in intake and excreta samples using inductively coupled plasma mass spectrometry",
      "procedureType": {
        "id": "3541917c-8cc9-4851-beba-f2e0e20f5136",
        "code": "Diagnostic",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic",
        "instanceType": "Code"
      },
      "code": {
        "id": "6ee70011-5971-40cc-93e7-2140a40167a5",
        "code": "82300",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Chemistry procedure, trace elements, not otherwise specified",
        "instanceType": "Code"
      }
    },
    {
      "id": "8bd86187-c3ac-4eb6-a1ed-39141f26921d",
      "name": "Neurological assessment",
      "instanceType": "Procedure",
      "label": "Neurologic examination",
      "description": "Neurological component of the physical examination and monitoring for neurologic adverse events, including potential worsening due to decoppering",
      "procedureType": {
        "id": "71fdadd5-6c50-46dd-9bcd-3372bb30405b",
        "code": "Assessment",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Assessment",
        "instanceType": "Code"
      },
      "code": {
        "id": "7d124d13-9499-4de3-86e2-f90d59ffd896",
        "code": "95992",
        "codeSystem": "CPT",
        "codeSystemVersion": "2024-09-27",
        "decode": "Canalith repositioning procedure(s) (e.g., Epley maneuver)",
        "instanceType": "Code"
      }
    }
  ],
  "medicalDevices": [
    {
      "id": "5600e000-1d9b-4691-a80a-70036c18abc5",
      "name": "Automated blood pressure monitor",
      "instanceType": "MedicalDevice",
      "label": "Automated vital signs monitor",
      "description": "Completely automated device used to measure blood pressure and heart rate for vital sign assessments",
      "deviceType": {
        "id": "2a76a44b-55a4-47f3-95ee-076959d3be1a",
        "code": "Monitoring Device",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Monitoring Device",
        "instanceType": "Code"
      }
    },
    {
      "id": "9f057d96-fc80-4dc9-9217-e56b7ba358ae",
      "name": "12-lead electrocardiograph",
      "instanceType": "MedicalDevice",
      "label": "12-lead ECG device",
      "description": "Device used to record triplicate 12-lead electrocardiograms for assessment of cardiac intervals and rhythm",
      "deviceType": {
        "id": "2c560f66-4f52-4081-adf0-6f07e309bb6f",
        "code": "Diagnostic Device",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic Device",
        "instanceType": "Code"
      }
    },
    {
      "id": "7e7b1d0b-d939-4076-be02-122bb24ac81a",
      "name": "Inductively Coupled Plasma Mass Spectrometer",
      "instanceType": "MedicalDevice",
      "label": "ICP-MS",
      "description": "Laboratory diagnostic device used to determine copper and molybdenum concentrations in biological and dietary samples",
      "deviceType": {
        "id": "ef2e0e45-841c-4dd2-b3e8-8078d5dd721c",
        "code": "Diagnostic Device",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic Device",
        "instanceType": "Code"
      }
    },
    {
      "id": "d54e6f39-a588-435f-9c30-2cc9fdb20064",
      "name": "Venous access cannula",
      "instanceType": "MedicalDevice",
      "label": "Peripheral intravenous cannula",
      "description": "Cannula placed for repeated blood draws to minimize needle sticks, not left in place longer than 72 hours and flushed at least every 8 hours",
      "deviceType": {
        "id": "08180225-f054-46b0-a4bb-59ca27b23bd8",
        "code": "Drug Delivery Device",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Drug Delivery Device",
        "instanceType": "Code"
      }
    },
    {
      "id": "916af068-226e-496c-b93b-07f6432d8e63",
      "name": "Automated hematology analyzer",
      "instanceType": "MedicalDevice",
      "label": "CBC analyzer",
      "description": "Laboratory analyzer used for complete blood count measurements",
      "deviceType": {
        "id": "6a8a50e6-92c1-4735-bb28-1f66706e1ee8",
        "code": "Diagnostic Device",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic Device",
        "instanceType": "Code"
      }
    },
    {
      "id": "0b2d0370-b3c1-47f7-a236-a5d911e976fc",
      "name": "Clinical chemistry analyzer",
      "instanceType": "MedicalDevice",
      "label": "Serum chemistry analyzer",
      "description": "Laboratory analyzer used to perform serum chemistry testing including liver function tests",
      "deviceType": {
        "id": "d1398336-296d-4f8a-8c98-3c1f725ebea6",
        "code": "Diagnostic Device",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Diagnostic Device",
        "instanceType": "Code"
      }
    }
  ],
  "ingredients": [
    {
      "id": "7f0ff7e1-edad-4335-9f0f-1482da62e16c",
      "name": "ALXN1840",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "e885c0b0-7edd-47e7-84ed-edc7e5487acd"
    },
    {
      "id": "7a3d5d32-8a54-4c7d-85be-d3fa5c859d18",
      "name": "Molybdenum (as component of tetrathiomolybdate complex in ALXN1840)",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "0f15d61f-046f-4386-b416-0d09e51dffa1"
    },
    {
      "id": "d92a5337-b6db-4791-a276-7560f7ad8df2",
      "name": "Copper (endogenous analyte)",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "aa549c86-c244-430b-8659-3e3710e6654a"
    },
    {
      "id": "f6c7e1ed-9927-4cde-9a58-c316b63f8aa7",
      "name": "Paracetamol (Acetaminophen)",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "cbf5566c-de85-4891-bc1a-79d622711909"
    },
    {
      "id": "bc5a8e6b-257b-4fd2-b442-8ac40330b1f5",
      "name": "Ibuprofen",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "298863f1-7637-4606-a00c-8a279fe21d0a"
    }
  ],
  "strengths": [
    {
      "id": "824ca9f1-3464-4cce-932c-f3a71d332376",
      "instanceType": "Strength",
      "value": 15,
      "unit": "mg",
      "numerator": {
        "value": 15,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "day"
      }
    },
    {
      "id": "31ce4fdc-4ea9-484a-b66c-0f17d2cfe947",
      "instanceType": "Strength",
      "value": 30,
      "unit": "mg",
      "numerator": {
        "value": 30,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "day"
      }
    },
    {
      "id": "f50696b9-5774-497d-9f68-29dc88d646e8",
      "instanceType": "Strength",
      "value": 60,
      "unit": "mg",
      "numerator": {
        "value": 60,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "dose"
      }
    },
    {
      "id": "1deb45bc-0950-494a-87c3-1c6d76173400",
      "instanceType": "Strength",
      "value": 1000,
      "unit": "mg",
      "numerator": {
        "value": 1000,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "day"
      }
    },
    {
      "id": "83fc6765-2359-4651-87f0-abe7dcfa0e5e",
      "instanceType": "Strength",
      "value": 1200,
      "unit": "mg",
      "numerator": {
        "value": 1200,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "24 h"
      }
    }
  ],
  "timings": [
    {
      "id": "f5116c7b-b3a0-4eb9-a8b9-6bebabd4e9dd",
      "name": "Run-in Period Duration",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 3,
      "relativeTo": "Study Start",
      "windowLower": -7,
      "windowUpper": -5
    },
    {
      "id": "55bffe6c-c9c6-4b77-9f26-729ded21a432",
      "name": "Pretreatment Copper/Molybdenum Baseline Collection",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 4,
      "relativeTo": "Study Start",
      "windowLower": -4,
      "windowUpper": -1
    },
    {
      "id": "f87ad004-d6dd-4cfe-b3e3-ea0c3e03721d",
      "name": "Initial 15 mg/day Treatment Duration Before Titration",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 28,
      "relativeTo": "First Dose",
      "windowLower": 1,
      "windowUpper": 28
    },
    {
      "id": "73dde024-21c2-4316-bd66-0a516b172e9d",
      "name": "Titration to 30 mg/day",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 29,
      "relativeTo": "First Dose",
      "windowLower": 29,
      "windowUpper": 29
    },
    {
      "id": "d9583adf-c344-41dd-a58e-7c7c9145195c",
      "name": "Safety Review for Dose Titration",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 23,
      "relativeTo": "First Dose",
      "windowLower": 1,
      "windowUpper": 23
    },
    {
      "id": "b263b837-b53c-4861-b404-2821760c308b",
      "name": "Intake/Output Collection Baseline Period",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 4,
      "relativeTo": "Study Start",
      "windowLower": -4,
      "windowUpper": -1
    },
    {
      "id": "243175e6-74b3-4217-9a55-ab03ddfe7592",
      "name": "Intake/Output Collection for 15 mg Initial Period",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 8,
      "relativeTo": "First Dose",
      "windowLower": 1,
      "windowUpper": 8
    },
    {
      "id": "9aa39fcb-c2d7-4443-be42-f3e12574c140",
      "name": "Intake/Output Collection Mixed 15 mg/30 mg Period",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 15,
      "relativeTo": "First Dose",
      "windowLower": 25,
      "windowUpper": 39
    },
    {
      "id": "680c5a16-0f7c-4848-8b76-df5a41dadb20",
      "name": "Accumulation Period to Steady State",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 10,
      "relativeTo": "First Dose",
      "windowLower": 1,
      "windowUpper": 10
    },
    {
      "id": "d5c3b5a9-95b9-4129-81df-4838fa802917",
      "name": "Possible Discharge from CRU After Inpatient Period 1",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 9,
      "relativeTo": "First Dose",
      "windowLower": 9,
      "windowUpper": 9
    },
    {
      "id": "081735f6-380c-45d1-b462-6b17e5df06b6",
      "name": "Readmission for Inpatient Period 2",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 2,
      "relativeTo": "First Dose",
      "windowLower": 22,
      "windowUpper": 23
    },
    {
      "id": "0b4fdd42-ba7c-4b75-a822-05559bfa1c51",
      "name": "Outpatient Period Maximum Extension",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 14,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 14
    },
    {
      "id": "75556b8a-d5bc-4798-9249-cb1c47ec1d4d",
      "name": "Inpatient Period 1 Duration",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 18,
      "relativeTo": "Study Start",
      "windowLower": -8,
      "windowUpper": 9
    },
    {
      "id": "22237e95-9717-4069-b9da-f2d6882b4bff",
      "name": "Inpatient Period 2 Duration",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 18,
      "relativeTo": "First Dose",
      "windowLower": 23,
      "windowUpper": 40
    },
    {
      "id": "8932be6f-83cd-429a-9d88-b26f7d258cc5",
      "name": "EOS Visit Window After Day 40",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 14,
      "relativeTo": "End of Treatment",
      "windowLower": 12,
      "windowUpper": 16
    },
    {
      "id": "fefaced2-daa6-4610-8fd5-1e386065af9c",
      "name": "EOS Visit Nominal Timing",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 54,
      "relativeTo": "First Dose",
      "windowLower": 52,
      "windowUpper": 56
    },
    {
      "id": "eae2ace0-212b-4216-861d-74347034788c",
      "name": "End of Study Blood Sampling Days",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 1,
      "relativeTo": "First Dose",
      "windowLower": 1,
      "windowUpper": 1
    },
    {
      "id": "e2a7421a-8660-4f66-9483-70963ca01e04",
      "name": "PK/PD 24-hour Collections",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 0,
      "relativeTo": "First Dose",
      "windowLower": 1,
      "windowUpper": 39
    },
    {
      "id": "a4b98e2e-99f3-405f-b075-57bc822a92d5",
      "name": "Predose PK/PD Sampling Days",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 0,
      "relativeTo": "First Dose",
      "windowLower": 4,
      "windowUpper": 38
    },
    {
      "id": "f17c6975-1c88-4dec-9768-9242151b03fb",
      "name": "Fasting Before Study Intervention in CRU",
      "type": "Before",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 10,
      "relativeTo": "First Dose",
      "windowLower": -10,
      "windowUpper": 0
    },
    {
      "id": "c906d45b-14d5-475a-8f7f-61c2d765d6ce",
      "name": "Allowed Deviation from Usual Dosing Time as Outpatient",
      "type": "Within",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 1,
      "relativeTo": "Previous Visit",
      "windowLower": -1,
      "windowUpper": 1
    },
    {
      "id": "d516ae0e-7967-48bb-8c2b-16b6c6dfc8dc",
      "name": "Meal Delay After ALXN1840 Dose",
      "type": "After",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 2,
      "relativeTo": "First Dose",
      "windowLower": 2,
      "windowUpper": 24
    },
    {
      "id": "f52adf70-c530-47d2-8bc9-7f6c221b87b1",
      "name": "Serum Chemistry Fasting Requirement at Screening and Check-in",
      "type": "Before",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 8,
      "relativeTo": "Screening",
      "windowLower": -8,
      "windowUpper": 0
    },
    {
      "id": "3e8dc061-3861-4d10-beec-91f84cf8f89c",
      "name": "Allowed Shorter Fast for Rechecks/Postdose Serum Chemistry",
      "type": "Before",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 6,
      "relativeTo": "Previous Visit",
      "windowLower": -6,
      "windowUpper": 0
    },
    {
      "id": "3ae85ac4-2edd-4b95-af04-6d7d4463500a",
      "name": "Laboratory Assessments Core Days",
      "type": "At",
      "unit": "days",
      "instanceType": "Timing",
      "value": 0,
      "relativeTo": "First Dose",
      "windowLower": -8,
      "windowUpper": 28
    },
    {
      "id": "e186b79c-5fb2-4823-8e1d-c61a10b56671",
      "name": "Home or Site Urine Pregnancy Testing Frequency",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 28,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 28
    },
    {
      "id": "8e0403cc-4adb-44a7-9138-1fb1ba0d1e54",
      "name": "24-hour Urine Collection Periods",
      "type": "Between",
      "unit": "days",
      "instanceType": "Timing",
      "value": 1,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 1
    },
    {
      "id": "e5a9fbbb-30ca-4646-a18c-3590f58a8792",
      "name": "Encouraged Voiding at End of 24-hour Period",
      "type": "Within",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 2,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 2
    },
    {
      "id": "e9914783-ece3-443b-9894-0e0d5c2af512",
      "name": "Chelator Discontinuation Before ALXN1840 Initiation",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 4,
      "relativeTo": "First Dose",
      "windowLower": -4,
      "windowUpper": -1
    },
    {
      "id": "e41a70c4-4cbd-429b-bf74-854b446a23eb",
      "name": "Zinc Discontinuation Prior to Day 1",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 21,
      "relativeTo": "First Dose",
      "windowLower": -21,
      "windowUpper": -1
    },
    {
      "id": "1be6d881-882d-4428-8519-e280c951e8d4",
      "name": "Prior Experimental Therapy Washout",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 90,
      "relativeTo": "Screening",
      "windowLower": -90,
      "windowUpper": -1
    },
    {
      "id": "ea772b5f-cf67-45e8-ba03-adca3c7f278d",
      "name": "Prescription Medication Washout",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 14,
      "relativeTo": "Screening",
      "windowLower": -14,
      "windowUpper": -1
    },
    {
      "id": "2aa3c408-ae3c-4d24-8015-75fd5dea28ac",
      "name": "Nonprescription Medication/Supplement Washout",
      "type": "Before",
      "unit": "days",
      "instanceType": "Timing",
      "value": 7,
      "relativeTo": "Screening",
      "windowLower": -7,
      "windowUpper": -1
    },
    {
      "id": "ca551c84-6b7e-461d-9215-4d50c33c73fc",
      "name": "Maximum Cannula Dwell Time",
      "type": "Within",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 72,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 72
    },
    {
      "id": "d6d16640-09c3-40a5-9771-7f1209140374",
      "name": "Cannula Flush Frequency",
      "type": "Within",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 8,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 8
    },
    {
      "id": "6170f6a0-bb69-458b-9b26-434951fd7f59",
      "name": "Maximum Number of Rechallenges",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 3,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 3
    },
    {
      "id": "18baaeb1-9077-4b18-a20e-77044799372b",
      "name": "Notification to Alexion for Clinically Concerning Abnormalities",
      "type": "Within",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 24,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 24
    },
    {
      "id": "aa37a68e-d88d-4561-9c31-a4b77149e5b6",
      "name": "Alcohol Abstinence Before Study Intervention Administration",
      "type": "Before",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 48,
      "relativeTo": "First Dose",
      "windowLower": -48,
      "windowUpper": 0
    },
    {
      "id": "92ef613c-28e2-4dfb-b655-f3f8f50ad580",
      "name": "Minimum Collection Period Length",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 3,
      "relativeTo": "Previous Visit",
      "windowLower": 3,
      "windowUpper": 3
    },
    {
      "id": "edfb8d99-b97a-4ed4-8f40-963417aeef49",
      "name": "Maximum Collection Period Length",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 15,
      "relativeTo": "Previous Visit",
      "windowLower": 15,
      "windowUpper": 15
    },
    {
      "id": "9ef4a65f-34a5-4292-b757-b0608d73b7fb",
      "name": "Bowel Transit Time Consideration",
      "type": "Within",
      "unit": "hours",
      "instanceType": "Timing",
      "value": 40,
      "relativeTo": "Previous Visit",
      "windowLower": 33,
      "windowUpper": 47
    },
    {
      "id": "3dc6bc90-0d10-405c-b48c-4b1ac1ae3d8d",
      "name": "Weekly Repeat Testing for Safety Laboratory Parameters",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 7,
      "relativeTo": "Previous Visit",
      "windowLower": 7,
      "windowUpper": 7
    },
    {
      "id": "b3649804-5d3b-429c-85d6-ea38cbbca828",
      "name": "Actions Prior to Declaring Lost to Follow-up",
      "type": "Within",
      "unit": "days",
      "instanceType": "Timing",
      "value": 3,
      "relativeTo": "Previous Visit",
      "windowLower": 0,
      "windowUpper": 3
    }
  ],
  "conditions": [
    {
      "id": "3aa41606-76f2-4e7b-9723-dc22d827aef1",
      "name": "Safety Review for Dose Increase to 30 mg",
      "instanceType": "Condition",
      "description": "Safety Review Committee evaluation prior to increasing dose from 15 mg/day to 30 mg/day",
      "text": "Before titration to 30 mg/day on Day 29, the Safety Review Committee will review available safety data through Day 23 for each participant."
    },
    {
      "id": "9a871410-ee86-4566-a066-80885ead741e",
      "name": "Continuation on 15 mg/day Instead of Titration",
      "instanceType": "Condition",
      "description": "Remain on 15 mg/day if safety concerns exist after approximately 4 weeks",
      "text": "Dosing for ALXN1840 will be initiated at 15 mg once daily for a minimum of 4 weeks, with an increase to 30 mg after 4 weeks, unless there are safety concerns that, in the opinion of the Investigator(s) and/or Alexion, may place participants at undue risk, in which case, participants may remain on the 15 mg/day dose for the duration of the study."
    },
    {
      "id": "62fed307-06e1-4b0e-9500-55ec92f130ba",
      "name": "Dose Modification Criteria General Rule",
      "instanceType": "Condition",
      "description": "Global rule to decrease or interrupt dose when predefined laboratory or clinical criteria are met",
      "text": "The dose should be decreased or interrupted if any of the relevant Dose Modification Criteria are met. Deviation from the dose modification guidelines must be agreed with the Alexion Medical Monitor."
    },
    {
      "id": "3e0a6fa6-82e1-4875-b366-8891105cd685",
      "name": "Hematologic Dose Reduction Criteria (Example)",
      "instanceType": "Condition",
      "description": "Criteria based on neutrophil decrease triggering dose reduction and restriction of increase",
      "text": ">30% decrease from baseline in participants with neutrophils below reference range at baseline: reduce dose to previous dose level if up-titration has occurred or reduce dose to 15 mg every other day if on 15 mg once daily. No further dose increase until resolution of abnormality."
    },
    {
      "id": "cfbd3a7d-1b97-4437-b10e-679602847f3d",
      "name": "Liver Injury Dose Interruption Criteria",
      "instanceType": "Condition",
      "description": "Bilirubin and ALT criteria requiring temporary interruption and specific conditions for rechallenge",
      "text": "If bilirubin > 2 × ULN accompanied by ALT > 3 × ULN, indicative of liver injury: temporarily interrupt ALXN1840; perform weekly repeat testing; rechallenge only at 15 mg every other day or less frequent when bilirubin is below ULN and with approval of the Alexion Medical Monitor. A maximum of 3 rechallenges will be allowed."
    },
    {
      "id": "2cc557ec-d088-4bbe-a51d-4c556a536382",
      "name": "Neurologic Worsening Management",
      "instanceType": "Condition",
      "description": "Criteria and process for dose modification in case of neurological worsening",
      "text": "Evidence of neurologic worsening by adverse events or by neurologic physical exam assessment will prompt the Investigator and Alexion Medical Monitor to evaluate the need for dose interruption, increase, or decrease based on copper control parameters and relevant clinical data; rationale must be documented and re-evaluated at the next study visit."
    },
    {
      "id": "88aa7bfd-b49f-488d-bb2f-124eca1f46c5",
      "name": "Psychiatric Worsening Management",
      "instanceType": "Condition",
      "description": "Criteria and process for dose modification in case of clinically significant psychiatric worsening",
      "text": "Evidence of clinically significant acute psychiatric worsening (including but not limited to suicidality, acute depression, or psychosis) will prompt the Investigator and Alexion Medical Monitor to evaluate the need for dose interruption, increase, or decrease based on copper control parameters and relevant clinical data; rationale must be documented and re-evaluated at the next study visit."
    },
    {
      "id": "4633a207-b1e7-4d4d-8364-0411dff0ffc5",
      "name": "Eligibility – Zinc Washout",
      "instanceType": "Condition",
      "description": "Minimum zinc-free period prior to starting ALXN1840 to avoid confounding copper balance",
      "text": "Participants must be off zinc therapy for a minimum of 21 days prior to Day 1 to prevent confounding of study results, as zinc works through upregulation of metallothionein in enterocytes resulting in elevated fecal copper excretion."
    },
    {
      "id": "6b7ba8dd-81fb-4433-b9db-d2f01c4a6759",
      "name": "Eligibility – Chelator Washout",
      "instanceType": "Condition",
      "description": "Required discontinuation of chelator therapy before ALXN1840 initiation for baseline copper assessment",
      "text": "To assess the copper baseline during the Inpatient Run-in Period, participants will be discontinued from their chelator therapy for approximately 4 days prior to initiating ALXN1840 while being maintained on a copper-controlled diet."
    },
    {
      "id": "55c9c7fb-29c8-4a05-a1a0-98dd9c079cc4",
      "name": "Eligibility – Prior ALXN1840 or Tetrathiomolybdate Exposure",
      "instanceType": "Condition",
      "description": "Exclusion based on prior ALXN1840 or tetrathiomolybdate within 1 year",
      "text": "Previous treatment with ALXN1840 or other form of tetrathiomolybdate within 1 year prior to dosing is exclusionary."
    },
    {
      "id": "09490b93-2c49-4288-9eb0-d3a5d64a88d7",
      "name": "Eligibility – Prior Experimental Therapy Washout",
      "instanceType": "Condition",
      "description": "Avoid carryover from other investigational therapies",
      "text": "Use of an experimental or unapproved/unlicensed therapy at the same time or within 90 days or 5 half-lives, whichever is longer, prior to the Screening Visit is exclusionary."
    },
    {
      "id": "fb9042d7-86fe-4a61-84e0-46fa0d521c62",
      "name": "Eligibility – Concomitant Medication Washout",
      "instanceType": "Condition",
      "description": "Abstain from prescription and nonprescription medications prior to study",
      "text": "Participants must abstain from taking prescription medications within 14 days or 5 half-lives (whichever is longer) of Day -7 or nonprescription drugs, vitamins, and dietary or herbal supplements within 7 days or 5 half-lives (whichever is longer) before Day -7 and until completion of the follow-up visit, except specific allowed medications."
    },
    {
      "id": "2832a8fa-4808-4339-afe1-42c850031df5",
      "name": "Eligibility – Pregnancy Testing and Status",
      "instanceType": "Condition",
      "description": "Requirement for negative pregnancy status and ongoing testing",
      "text": "Women of childbearing potential should only be enrolled after a negative serum pregnancy test result at Screening. Additional urine pregnancy testing will be standard at protocol-defined visits, and females of childbearing potential must perform urine pregnancy tests at least every 4 weeks at their home or the study site throughout their time in the study."
    },
    {
      "id": "d1ecdaef-2eb8-475c-b920-2b9b0d8cb6f0",
      "name": "Eligibility – Ability to Tolerate Controlled Diet",
      "instanceType": "Condition",
      "description": "Requirement to complete and tolerate controlled copper/molybdenum diet",
      "text": "Participants unwilling to consistently complete every meal and tolerate a controlled, limited menu for the duration of the study are excluded. Participants will remain on a copper/molybdenum-controlled diet throughout inpatient Period 1 and 2 and are strongly encouraged to complete all meals."
    },
    {
      "id": "7ab3db85-7a30-473e-adb9-06764326598b",
      "name": "Discontinuation of Study Intervention – Triggering Conditions",
      "instanceType": "Condition",
      "description": "Conditions mandating consideration of permanent discontinuation of ALXN1840",
      "text": "Participants must be considered for discontinuation from study intervention if any of the following occur: serious hypersensitivity reaction; severe uncontrolled infection; use of disallowed medication; pregnancy or planned pregnancy; or if Alexion or the Investigator deems it necessary."
    },
    {
      "id": "df151382-989a-42dc-8207-90dc678acfef",
      "name": "Discontinuation for Abnormal Liver Function",
      "instanceType": "Condition",
      "description": "Link to dose modification criteria for liver-related discontinuation decisions",
      "text": "Discontinuation of study intervention for abnormal liver function should be considered when a participant meets one of the conditions outlined in the Dose Modification criteria or if the Investigator believes that it is in the best interest of the participant."
    },
    {
      "id": "87fc5366-8329-4984-99d2-252f127edf12",
      "name": "Clinically Significant ECG Findings Post-enrollment",
      "instanceType": "Condition",
      "description": "Decision on continued participation based on ECG abnormalities",
      "text": "If a clinically significant finding is identified on ECG (including changes from baseline in QTcF) after enrollment, the Investigator or qualified designee will determine if the participant can continue in the study and if any change in participant management is needed."
    },
    {
      "id": "451e2e97-310f-4fae-b2f1-dbaa784b17d7",
      "name": "Adaptive Design Features",
      "instanceType": "Condition",
      "description": "Investigator discretion for adaptive features within defined limits without protocol amendment",
      "text": "This study incorporates the use of an adaptive design. Adaptive features may be implemented at the discretion of the Investigator to support conduct of the study and do not require amendment of the protocol; adaptive features and their limits are described in Table 4."
    },
    {
      "id": "d0a9b395-65e5-43a9-bf87-6f9e71e026f8",
      "name": "Lost to Follow-up Determination",
      "instanceType": "Condition",
      "description": "Conditions under which a participant is considered lost to follow-up",
      "text": "A participant will be considered lost to follow-up if he or she repeatedly fails to return for scheduled visits and is unable to be contacted by the study site despite at least 3 telephone calls and, if necessary, a certified letter to the last known mailing address, with all attempts documented."
    },
    {
      "id": "18f62c96-9033-4b17-8e23-dd8451f39fe8",
      "name": "Maximum Number of Dose Rechallenges",
      "instanceType": "Condition",
      "description": "Limit on rechallenge attempts after safety-related interruption",
      "text": "A maximum of 3 rechallenges will be allowed for participants in whom ALXN1840 was interrupted per dose modification criteria."
    }
  ],
  "transitionRules": [
    {
      "id": "be12329f-ecc7-4055-a930-b0011bc5bb36",
      "name": "Screening/Run-in to Treatment Transition",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "5114fca6-c83c-4147-b7df-b1e0a317d108",
      "toElementId": "e00edc31-d609-4e41-97b5-b332b08cfb7f",
      "text": "Participants eligible for the study will be enrolled on Day -7 and initiated on a copper- and molybdenum-controlled diet, then admitted to the CRU for Treatment Period 1 on Day -8 and start ALXN1840 at 15 mg/day on Day 1 following discontinuation of chelator therapy for approximately 4 days and zinc therapy for at least 21 days."
    },
    {
      "id": "515a9414-0e79-4623-b3f4-0d58a18ffae9",
      "name": "Dose Escalation from 15 mg/day to 30 mg/day",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "fromElementId": "7fcfe087-a44c-428e-a15d-270256a78a73",
      "toElementId": "b01c3d80-9676-41ea-b1a2-86a00cd83170",
      "text": "Participants will be administered ALXN1840 at a dose of 15 mg/day on Day 1 through Day 28 and then increase to 30 mg/day on Day 29 after the Safety Review Committee reviews available safety data through Day 23. If safety concerns exist, participants may remain on 15 mg/day for the duration of the study."
    },
    {
      "id": "6d5642fb-e923-4880-beb3-0e5262c64921",
      "name": "Dose Reduction or Interruption Based on Safety Criteria",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "fromElementId": "b896b8f1-2b03-4589-97af-579a63fe9eb5",
      "toElementId": "b62b5bf1-9e12-4948-b344-cd52ab28763f",
      "text": "The dose should be decreased or interrupted if any of the relevant Dose Modification Criteria in Table 7 are met, such as hematological abnormalities, liver test abnormalities, neurologic or psychiatric worsening. Deviation from these guidelines must be agreed with the Alexion Medical Monitor."
    },
    {
      "id": "ea655cee-8326-4719-a842-cf1f367ed9bd",
      "name": "Temporary Interruption for Liver Injury",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "fromElementId": "b896b8f1-2b03-4589-97af-579a63fe9eb5",
      "toElementId": "8f3b0703-cd3e-41df-a350-ca552b02332b",
      "text": "If bilirubin > 2 × ULN accompanied by ALT > 3 × ULN indicative of liver injury occurs, ALXN1840 dosing should be temporarily interrupted, with weekly repeat testing; rechallenge, if considered, is at 15 mg every other day or less frequent when bilirubin is below ULN and requires approval of the Alexion Medical Monitor."
    },
    {
      "id": "2135f662-c337-4ebf-a20f-2f11302a1571",
      "name": "Dose Rechallenge After Safety Event",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "fromElementId": "8f3b0703-cd3e-41df-a350-ca552b02332b",
      "toElementId": "b57012b9-ffcc-4aa7-88bf-1c5dd2f1157d",
      "text": "Following resolution of safety abnormalities triggering dose interruption, participants may be rechallenged, typically at 15 mg every other day, up to a maximum of 3 rechallenges; dose and frequency may be changed by the Investigator in consultation with the Medical Monitor."
    },
    {
      "id": "e90dfbc3-68d8-44ea-ac77-9a871e303f61",
      "name": "Discontinuation of Study Intervention for Safety",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "fromElementId": "b896b8f1-2b03-4589-97af-579a63fe9eb5",
      "toElementId": "1c0b8609-92e5-466f-b3dc-d22166da245c",
      "text": "Participants must be considered for discontinuation from study intervention if serious hypersensitivity reaction, severe uncontrolled infection, use of disallowed medication, pregnancy or planned pregnancy occurs, or if Alexion or the Investigator deems discontinuation is necessary."
    },
    {
      "id": "e7bfa8e2-82a6-4df5-b81c-1b444461aafc",
      "name": "Discontinuation of Study Intervention for Abnormal Liver Function",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "fromElementId": "b896b8f1-2b03-4589-97af-579a63fe9eb5",
      "toElementId": "1c0b8609-92e5-466f-b3dc-d22166da245c",
      "text": "Discontinuation of study intervention for abnormal liver function should be considered when liver-related dose modification criteria are met or when the Investigator believes it is in the best interest of the participant."
    },
    {
      "id": "11f88cdb-8795-43b4-92c3-5cb0dec44ee0",
      "name": "Participant Withdrawal from Study",
      "instanceType": "TransitionRule",
      "transitionType": "Early Termination",
      "fromElementId": "863a3921-36e0-457a-bee9-4c74da6f9175",
      "toElementId": "323d0df8-9ffd-465d-8084-ccfbc793e920",
      "text": "A participant may withdraw from the study at any time at his/her own request, or may be withdrawn at the discretion of the Investigator for safety, behavioral, compliance, or administrative reasons; an early discontinuation visit should be conducted if possible and the participant is permanently discontinued from both study intervention and study participation."
    },
    {
      "id": "b010df7b-fce4-4165-9d6c-5c41c7c34d12",
      "name": "Lost to Follow-up Leading to Withdrawal",
      "instanceType": "TransitionRule",
      "transitionType": "Early Termination",
      "fromElementId": "863a3921-36e0-457a-bee9-4c74da6f9175",
      "toElementId": "323d0df8-9ffd-465d-8084-ccfbc793e920",
      "text": "If a participant repeatedly fails to return for scheduled visits and remains unreachable despite at least 3 telephone calls and, if necessary, a certified letter, he/she will be considered to have withdrawn from the study and will be permanently discontinued."
    },
    {
      "id": "bc60c0c2-ef03-4494-b101-5b5d79ce8a67",
      "name": "Transition to Post-study Therapy",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "ead67af2-9b6d-444b-8886-6a670b5ccf0d",
      "toElementId": "e3e9de05-60b0-40db-8ac7-59b2d0a49d31",
      "text": "Following completion of both inpatient periods (Day 40), participants will either transition to therapy that was discontinued before enrollment, transition to other standard of care therapy as directed by the treating physician, or, at the discretion of the treating physician, consider continuation of ALXN1840 treatment under preapproval access."
    },
    {
      "id": "942726ef-bf45-4660-9993-41060bb78561",
      "name": "Study-site Closure or Study Termination",
      "instanceType": "TransitionRule",
      "transitionType": "Early Termination",
      "fromElementId": "fbe9f4f7-a5c5-409c-8dfc-79db12e4acc0",
      "toElementId": "a95e3098-9f98-4ded-a563-4b130ea49136",
      "text": "Alexion may close a study site or terminate the study at any time for reasons including but not limited to Investigator non-compliance, inadequate recruitment, or discontinuation of further study intervention development; the Investigator may also initiate site closure given reasonable cause and sufficient notice."
    }
  ],
  "scheduleTimelineExits": [
    {
      "id": "53d229ef-36df-4366-8023-a615c61fd1a4",
      "name": "Study Completion for Participant",
      "exitType": "Completion",
      "instanceType": "ScheduleTimelineExit",
      "description": "A participant is considered to have completed the study if he or she has completed all phases of the study including the last scheduled procedure shown in the Schedule of Activities, typically the End of Study Visit on Day 54 (±2 days)."
    },
    {
      "id": "99972dfb-cfeb-4baf-b7e5-e157c300f99d",
      "name": "Early Termination – Participant Withdrawal or Investigator Decision",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "Early termination occurs when a participant withdraws consent at any time or is withdrawn at the discretion of the Investigator for safety, behavioral, compliance, or administrative reasons; an early discontinuation visit should be performed per the SoA."
    },
    {
      "id": "0213bbfc-98b9-4981-adc8-b2598e9f606f",
      "name": "Early Termination – Lost to Follow-up",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "If a participant repeatedly fails to return for scheduled visits and cannot be contacted despite documented attempts (at least 3 telephone calls and, if necessary, a certified letter), the participant is considered to have withdrawn from the study and is permanently discontinued."
    },
    {
      "id": "d36f3b07-66ba-4909-8455-2f15c3802139",
      "name": "Discontinuation of Study Intervention Only",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "In rare instances, the study intervention may be permanently discontinued for a participant while the participant remains in the study for safety follow-up; this occurs in the setting of serious hypersensitivity, severe uncontrolled infection, pregnancy, use of disallowed medication, or other safety reasons per Investigator or Sponsor judgment."
    },
    {
      "id": "482dd102-9155-4807-aae8-3ad0fc67c518",
      "name": "Site-level Early Closure",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "A study site may be closed before planned completion due to Investigator non-compliance with protocol or GCP, inadequate recruitment, or discontinuation of further study intervention development; all participants at the site must complete early discontinuation or end-of-study visits as applicable."
    },
    {
      "id": "a5653083-82b0-418c-aa09-45c50ae47341",
      "name": "Study-level Early Termination",
      "exitType": "Early Termination",
      "instanceType": "ScheduleTimelineExit",
      "description": "Alexion reserves the right to terminate the study at any time; in such cases all Investigators, ethics committees, regulatory authorities, and participants are informed, and appropriate participant therapy and/or follow-up is assured."
    }
  ],
  "analysisPopulations": [
    {
      "id": "0edf4e27-05de-40e4-bce6-241bc77fe6ca",
      "name": "Screened Set",
      "populationType": "Other",
      "instanceType": "AnalysisPopulation",
      "label": "SSCR",
      "description": "All participants who signed informed consent and underwent any screening assessments",
      "criteria": "All participants who provided informed consent and had any screening procedure performed"
    },
    {
      "id": "e5adbba9-e77e-4dfb-a897-e5364222116b",
      "name": "Enrolled Set",
      "populationType": "Other",
      "instanceType": "AnalysisPopulation",
      "label": "ENR",
      "description": "All participants who were enrolled into the study (typically on Day -7) according to the protocol",
      "criteria": "All participants who met eligibility criteria and were formally enrolled in the study"
    },
    {
      "id": "b8e09c65-881f-486d-a88f-e5e694de2309",
      "name": "Full Analysis Set",
      "populationType": "Efficacy",
      "instanceType": "AnalysisPopulation",
      "label": "FAS",
      "description": "Primary efficacy analysis population, generally aligned with the ICH E9 intent‑to‑treat principle",
      "criteria": "All enrolled participants who received at least 1 dose of ALXN1840 and have sufficient intake/output data to contribute to copper/molybdenum balance assessments"
    },
    {
      "id": "1feeb2cf-5f13-4085-84e7-4a3dd357678f",
      "name": "Per Protocol Set",
      "populationType": "Efficacy",
      "instanceType": "AnalysisPopulation",
      "label": "PP",
      "description": "Subset of the Full Analysis Set without major protocol deviations that could affect primary efficacy evaluation; used for sensitivity analyses when the PP Set has at least 3 participants",
      "criteria": "Participants in the Full Analysis Set who have no major protocol deviations judged to impact the assessment of copper/molybdenum balance, and who complete required baseline and on‑treatment collection periods"
    },
    {
      "id": "99a9e5e5-18de-47b7-a5b4-f04843bc966c",
      "name": "Safety Set",
      "populationType": "Safety",
      "instanceType": "AnalysisPopulation",
      "label": "SAF",
      "description": "Population used for all safety analyses including adverse events, laboratory tests, vital signs, ECGs, and exposure",
      "criteria": "All participants who received at least 1 dose of ALXN1840"
    },
    {
      "id": "96ce7c23-ec34-4b92-8810-16bac675c81e",
      "name": "Pharmacokinetic Analysis Set",
      "populationType": "PK",
      "instanceType": "AnalysisPopulation",
      "label": "PKAS",
      "description": "Population used for PK concentration and parameter analyses of ALXN1840 and molybdenum",
      "criteria": "All participants who received at least 1 dose of ALXN1840 and have at least one evaluable PK sample (e.g. on Days 1, 25, 29, or 39) without significant PK-related protocol deviations"
    },
    {
      "id": "f9272979-9bec-41e7-9e25-281b26a652bb",
      "name": "Pharmacodynamic Analysis Set",
      "populationType": "PD",
      "instanceType": "AnalysisPopulation",
      "label": "PDAS",
      "description": "Population used for PD analyses related to copper disposition and PD biomarkers (e.g., plasma copper measures)",
      "criteria": "All participants who received at least 1 dose of ALXN1840 and have at least one evaluable PD measurement as per protocol (e.g. during intake/output collection periods) and no major PD-related protocol deviations"
    }
  ],
  "characteristics": [
    {
      "id": "250af54f-ee49-4f64-9a6a-d145d9325530",
      "name": "Age",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Age in years at reference date (typically date of informed consent or first dose, per SAP Appendix 9.2.2 on age and dates)"
    },
    {
      "id": "297793b6-fb21-455c-8d22-bcb19f61b200",
      "name": "Sex",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Sex of participant as recorded on CRF (e.g. male, female)"
    },
    {
      "id": "4cd635a7-3045-4528-8b3c-ca0ba529b37c",
      "name": "Race",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Race as collected on demographics CRF (e.g. White, Black or African American, Asian, etc.)"
    },
    {
      "id": "74e8580c-b7f7-4725-80e2-33a701425242",
      "name": "Ethnicity",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Ethnicity as collected on demographics CRF (e.g. Hispanic or Latino, Not Hispanic or Latino)"
    },
    {
      "id": "68ab6f1f-dcaa-405f-bb8c-6ea9428487ff",
      "name": "Body Mass Index",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Body mass index calculated from height and weight at baseline, per SAP Appendix 9.2.5"
    },
    {
      "id": "aa4ef221-4636-4c20-a0e7-979b029ca52c",
      "name": "Baseline Disease Characteristics – Wilson Disease History",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Wilson Disease (WD) history including age at diagnosis, disease duration, clinical presentation, and relevant disease status at baseline, as summarized in Section 7.1.3.2 and 7.1.3.3"
    },
    {
      "id": "256b9f5f-d144-4a18-9984-58b79f003707",
      "name": "Baseline Copper Balance",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Mean daily copper balance during pretreatment baseline (Days -4 through -1), measured as intake (food and drink) minus output (feces and urine)"
    },
    {
      "id": "7cffd7f6-16a0-4ac5-9eb2-b683b1190864",
      "name": "Baseline Molybdenum Balance",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Mean daily molybdenum balance during pretreatment baseline (Days -4 through -1), analogous to copper balance"
    },
    {
      "id": "f31063ff-a8fd-44ab-a1c8-37675bb1477b",
      "name": "Baseline Copper Intake",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Total daily copper intake from food, drink, and study drug during the baseline collection period (Days -4 through -1)"
    },
    {
      "id": "e42ac6c9-6347-4b5c-9b35-23f925673188",
      "name": "Baseline Copper Output – Urine",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Daily urinary copper excretion during the pretreatment baseline period"
    },
    {
      "id": "7718bb91-bb79-407b-84ac-be72614784da",
      "name": "Baseline Copper Output – Feces",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Daily fecal copper excretion during the pretreatment baseline period"
    },
    {
      "id": "8f766721-b38e-4fa4-94a5-f306f1df0431",
      "name": "Baseline Molybdenum Intake",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Total daily molybdenum intake from food, drink, and study drug during the baseline collection period"
    },
    {
      "id": "c44b55bd-e8e2-43e1-bc40-15fb887e5d6d",
      "name": "Baseline Molybdenum Output – Urine",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Daily urinary molybdenum excretion during the pretreatment baseline period"
    },
    {
      "id": "75b770a7-41d8-495b-af37-34da4067b055",
      "name": "Baseline Molybdenum Output – Feces",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Daily fecal molybdenum excretion during the pretreatment baseline period"
    },
    {
      "id": "21edae2b-1e48-4654-8415-e7a250d81546",
      "name": "Baseline Plasma Copper Measures",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Baseline plasma copper-related measures such as total copper and labile bound copper (LBC), as part of disease characteristics/PD profile"
    },
    {
      "id": "04aa0596-927b-40bf-88ca-2289feee3ea5",
      "name": "Baseline Plasma Molybdenum",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Baseline plasma total molybdenum concentration"
    },
    {
      "id": "74be6532-336c-4b3e-b3e5-70537c2b267d",
      "name": "Medical and Surgical History",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Relevant prior medical and surgical history including comorbidities related to WD and other conditions (Section 7.1.3.3)"
    },
    {
      "id": "87a460e5-1c63-4df9-993a-5b301e50c44e",
      "name": "Prior WD Therapies",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "History of prior and ongoing therapies for Wilson Disease (e.g., penicillamine, trientine, zinc, prior ALXN1840), including duration >28 days vs ≤28 days used to define Cohort 1 (treatment-experienced) and Cohort 2 (treatment-naïve)"
    },
    {
      "id": "5ec16e74-e5dd-4f0d-8217-aab9db03e3a2",
      "name": "Prior and Concomitant Medications/Therapies",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "All prior and concomitant medications and therapies summarized by Anatomical Therapeutic Chemical (ATC) class and preferred name, including those used to treat WD as noted in Section 7.1.4 and Appendix 9.2.7"
    },
    {
      "id": "47495d73-ff82-4e31-b024-c1437cee60aa",
      "name": "Baseline Laboratory Assessments",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Baseline clinical laboratory parameters (e.g., liver enzymes ALT, AST, GGT; INR; other safety labs) used to describe disease status and safety profile at baseline"
    },
    {
      "id": "4863e7b1-d1a4-4244-90db-cc413c8e7c8b",
      "name": "Baseline Vital Signs",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Vital signs at baseline (e.g., blood pressure, heart rate, respiratory rate, body temperature), summarized per Section 7.3.3.2"
    },
    {
      "id": "b7c2b5ce-f8ed-4cbc-b284-2dd83b6de33b",
      "name": "Baseline ECG Parameters",
      "dataType": "Numeric",
      "instanceType": "Characteristic",
      "description": "Baseline electrocardiogram parameters (e.g., QT, QTc, QTcF) summarized per Section 7.3.3.4"
    },
    {
      "id": "4a1b1e52-2b9d-4a81-b862-151678d97718",
      "name": "Cohort (Treatment-experienced vs Treatment-naïve)",
      "dataType": "Categorical",
      "instanceType": "Characteristic",
      "description": "Cohort classification based on prior WD therapy exposure: Cohort 1 (treatment experienced, >28 days of WD therapy) vs Cohort 2 (treatment naïve, ≤28 days of WD therapy)"
    }
  ],
  "documentContentReferences": [
    {
      "id": "f6eef24d-c7a0-4cd3-a570-c3bce2cbee55",
      "name": "Screening procedures clarified in Section 8",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "1.3",
      "sectionTitle": "Schedule of Activities (SoA), Table 1",
      "description": "Amendment summary states that a footnote in the Schedule of Activities table is updated to state that procedures specific to screening sites (US only) are detailed in Section 8."
    },
    {
      "id": "85cc45c4-54db-44ff-86d6-f7a4de937dd9",
      "name": "US-specific screening sites detail",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8",
      "sectionTitle": "Study Assessments and Procedures",
      "description": "Amendment summary notes that Section 8 adds text applicable only to the US detailing the possibility for sites to perform only screening procedures and not remaining study procedures."
    },
    {
      "id": "fa1805aa-0b98-482a-b12a-92ec7dd475bf",
      "name": "COVID-19 vaccine risk assessment",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "2.3.1.1",
      "sectionTitle": "Coronavirus (SARS-CoV-2) Disease 2019",
      "description": "Text notes that specific consideration has been given to potential risks and mitigation measures due to the COVID-19 vaccine and directs the reader to Section 10.5."
    },
    {
      "id": "ea3d43be-6111-407a-9b8a-6c6c698eb300",
      "name": "Dose modification reference in risk table",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "2.3.1",
      "sectionTitle": "Risk Assessment",
      "description": "Within Table 3, the mitigation strategy for several risks includes dose modification or discontinuation with a reference to Section 6.6 for details of dose modification criteria."
    },
    {
      "id": "a65abdf3-0a54-4890-8465-7904da2271f1",
      "name": "Outpatient period extension limits",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.1",
      "sectionTitle": "Overall Design",
      "description": "Text describing adaptive design indicates that adaptive features and their limits are detailed in Table 4."
    },
    {
      "id": "e10b3498-ce48-4dbd-b81f-5e205170ed63",
      "name": "Dose modification criteria linkage",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "4.1",
      "sectionTitle": "Overall Design",
      "description": "Adaptive feature 4 in Table 4 refers to relevant Dose Modification criteria defined in Table 7."
    },
    {
      "id": "ec03b061-7c71-49f6-8725-68da72b5bc53",
      "name": "Blood donation exclusion cross-reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.3",
      "sectionTitle": "Lifestyle Considerations",
      "description": "In the lifestyle restriction table, the restriction on blood and plasma donation refers to an exclusion criterion defined in Section 5.2."
    },
    {
      "id": "e8df2632-370a-43b2-a20c-2e917ac4023b",
      "name": "Contraception cross-reference from lifestyle considerations",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.3",
      "sectionTitle": "Lifestyle Considerations",
      "description": "Contraception requirements reference appropriate contraceptive methods described in Section 10.4 and start times for contraceptives according to methods described in Section 5.1."
    },
    {
      "id": "c9b0dd68-11bf-4ee4-9227-3bf7ddb79f4b",
      "name": "Schedule of Activities for study intervention discontinuation",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "7.1",
      "sectionTitle": "Discontinuation of Study Intervention",
      "description": "Directs readers to the Schedule of Activities in Section 1.3 for data to be collected at the time of discontinuation of study intervention and follow-up."
    },
    {
      "id": "f971480b-3ce6-47c1-9310-be3f94bd62b7",
      "name": "Dose modification criteria for abnormal liver function",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "7.1",
      "sectionTitle": "Discontinuation of Study Intervention",
      "description": "States that discontinuation of study intervention for abnormal liver function should be considered when conditions outlined in the Dose Modification criteria in Section 6.6 are met."
    },
    {
      "id": "f4323d31-2259-49bc-a64e-a795428d4bbb",
      "name": "Pregnancy discontinuation criteria",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "7.1",
      "sectionTitle": "Discontinuation of Study Intervention",
      "description": "Lists pregnancy or planned pregnancy as a reason for discontinuation and cross-refers to Section 8.2.6 for pregnancy details."
    },
    {
      "id": "6e27df8b-3d84-43af-99e9-64cde5c37ba9",
      "name": "Table 1 reference for discontinuation visit procedures",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "7.1",
      "sectionTitle": "Discontinuation of Study Intervention",
      "description": "Instructs to see the Schedule of Activities (Table 1) for samples and data to be collected at the time of study intervention discontinuation and follow-up."
    },
    {
      "id": "3b0875b2-4e02-447a-9487-f0bfd8a8da8d",
      "name": "Schedule of Activities for early discontinuation",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "7.2",
      "sectionTitle": "Participant Discontinuation/Withdrawal From the Study",
      "description": "Indicates that an early discontinuation visit should be conducted as shown in the Schedule of Activities and that Section 1.3 should be consulted for data to be collected at study discontinuation and follow-up."
    },
    {
      "id": "f310571e-0440-440b-a58a-ffa3598864e4",
      "name": "ECG withdrawal criteria linkage",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.2.3",
      "sectionTitle": "Electrocardiograms",
      "description": "Specifies that triplicate ECGs will be conducted as outlined in the SoA (Section 1.3) and refers to Section 7 for QTc withdrawal criteria and any additional QTc readings."
    },
    {
      "id": "c1f00107-9197-47f6-b9ca-c2d912e821a0",
      "name": "Clinical laboratory test list and timing",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.2.4",
      "sectionTitle": "Clinical Safety Laboratory Assessments",
      "description": "Directs the reader to Section 10.2 for the list of clinical laboratory tests and to the SoA (Section 1.3) for timing and frequency of assessments."
    },
    {
      "id": "fa370c87-4e6e-4b76-9af2-18744ef9ccb2",
      "name": "Protocol-required laboratory assessments definition",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.2.4",
      "sectionTitle": "Clinical Safety Laboratory Assessments",
      "description": "States that all protocol-required laboratory assessments, as defined in Section 10.2, must be conducted according to the laboratory manual and the SoA."
    },
    {
      "id": "137c6634-eca3-4fd3-b115-8226260736ba",
      "name": "AE/SAE linkage to discontinuation section",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.3",
      "sectionTitle": "Adverse Events and Serious Adverse Events",
      "description": "Notes that investigators remain responsible for following up AEs that caused the participant to discontinue the study intervention, with a cross-reference to Section 7 for discontinuation details."
    },
    {
      "id": "15ee3739-0148-495f-affe-4024f3410eed",
      "name": "Procedures for AE and SAE handling",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.3",
      "sectionTitle": "Adverse Events and Serious Adverse Events",
      "description": "States that procedures for recording, evaluating, follow-up, and reporting AEs and SAEs are outlined in Section 10.3."
    },
    {
      "id": "d16873e0-66f4-41be-8518-1da6fc23e176",
      "name": "SAE reporting timelines cross-reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.3.1",
      "sectionTitle": "Time Period and Frequency for Collecting AE and SAE Information",
      "description": "Indicates that all SAEs must be recorded and reported as indicated in Section 10.3."
    },
    {
      "id": "bd26a237-b640-4592-b31a-dc345ffa720e",
      "name": "AE/SAE detection and reporting methods",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.3.2",
      "sectionTitle": "Method of Detecting AEs and SAEs",
      "description": "Specifies that methods for recording, evaluating, assessing causality, and completing and transmitting SAE reports are provided in Section 10.3."
    },
    {
      "id": "ed8a1ee8-b60d-49ec-b48a-0dc49ebf5faa",
      "name": "Lost to follow-up definition",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.3.3",
      "sectionTitle": "Follow-up of AEs and SAEs",
      "description": "States that SAEs will be followed until resolution, stabilization, explanation, or participant is lost to follow-up as defined in Section 7.3."
    },
    {
      "id": "179fbb41-055f-4b6c-91a3-11d7c012a2ad",
      "name": "Biobanked sample genetic testing exclusion",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.3.6",
      "sectionTitle": "Retained and Biobanked Sample",
      "description": "Clarifies that the retained biobanked sample will not be used for genetic testing and refers to Section 8.7 for genetics."
    },
    {
      "id": "f7ea772d-229a-443f-b2ec-cc69ebbe816a",
      "name": "PK sampling schedule",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.5",
      "sectionTitle": "Pharmacokinetics",
      "description": "Specifies that whole blood samples for molybdenum measurements will be collected as specified in the SoA (Table 1)."
    },
    {
      "id": "ab95f305-ddaf-40b1-8653-cde49dbeb1b0",
      "name": "Copper balance measurements cross-reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.5",
      "sectionTitle": "Pharmacokinetics",
      "description": "Directs readers to Section 8.1.1 for details of molybdenum measured in food, drinks, urine, and feces."
    },
    {
      "id": "43853c97-9349-4206-be25-67d81d384ebf",
      "name": "PD sampling schedule",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.6",
      "sectionTitle": "Pharmacodynamics",
      "description": "States that blood samples for PD endpoints will be collected as described in the SoA (Table 1) for plasma isolation."
    },
    {
      "id": "dd1e8d02-c9c2-427c-b30d-0c31a1856962",
      "name": "Copper and biomarker measurement details",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.8",
      "sectionTitle": "Biomarkers",
      "description": "Refers readers to Section 8.6 for details of plasma copper-related biomarkers and to Section 8.1.1 for details of copper measured in food, drink, urine, and feces."
    },
    {
      "id": "07dde4b9-9a49-4e71-918f-2f83430fa549",
      "name": "Populations for analysis table",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "9.3",
      "sectionTitle": "Populations for Analyses",
      "description": "Indicates that the population sets used for analysis are defined in Table 8."
    },
    {
      "id": "e18b917c-3d70-4598-9dfe-7e4a2517afcc",
      "name": "Use of PK/PD Analysis Set",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "9.4.4",
      "sectionTitle": "Pharmacokinetic, Pharmacodynamic, and Biomarker Analyses",
      "description": "States that analyses for PK, PD, and biomarker endpoints will be performed using the PK/PD Analysis Set described in Table 8."
    },
    {
      "id": "390bd17a-7413-45ae-a303-7822ea85b743",
      "name": "ECG analysis and SoA linkage",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "9.4.3",
      "sectionTitle": "Safety Analyses",
      "description": "Indicates that electrocardiogram parameters will be measured at specified time points as per the SoA (Table 1)."
    },
    {
      "id": "5c44d80a-2fb1-4e99-9df1-ffd31a5f610f",
      "name": "IRB/IEC safety notifications",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "8.3.4",
      "sectionTitle": "Regulatory Reporting Requirements for SAEs",
      "description": "States that an Investigator who receives an Investigator safety report describing an SAE or other safety information from Alexion will file it with the IB and notify the IRB/IEC according to local requirements."
    },
    {
      "id": "1aa8d95a-8230-4f27-b5f3-3d2f5471dee8",
      "name": "Risk rationale referencing IB",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "2.3.1",
      "sectionTitle": "Risk Assessment",
      "description": "Within Table 3, several risk rationales cite results obtained from studies of ALXN1840 and ammonium tetrathiomolybdate in participants with Wilson disease and instruct the reader to see the Investigator’s Brochure (IB)."
    }
  ],
  "commentAnnotations": [
    {
      "id": "50433b65-a57c-4159-9dfe-36af15aa1543",
      "text": "Abbreviations: ALT = alanine aminotransferase; AST = aspartate aminotransferase; IB = Investigator’s Brochure; PK = pharmacokinetics; WD = Wilson disease.",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "2.3.1 Risk Assessment / Table 3: Potential Risks and Mitigation Strategy",
      "pageNumber": 21
    },
    {
      "id": "dbef3ad9-7c0d-4316-b723-1ee0e6d6d1c7",
      "text": "Abbreviations: CRF = case report form; CRU = clinical research unit; EOS = End of Study; SoA = Schedule of Activities.",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "5.3 Lifestyle Considerations",
      "pageNumber": 35
    },
    {
      "id": "a49c6411-8bf9-4c33-b166-79b1b5e6eea0",
      "text": "Abbreviations: ICF = informed consent form; PD = pharmacodynamic; PK = pharmacokinetic.",
      "annotationType": "Clarification",
      "instanceType": "CommentAnnotation",
      "sourceSection": "9.3 Populations for Analyses / Table 8: Populations for Analysis",
      "pageNumber": 51
    },
    {
      "id": "e901145d-40cf-4fdf-9cae-337aea84665b",
      "text": "Note: total molybdenum and PUF molybdenum concentration-time profiles on Day 28 after the last 15 mg ALXN1840 dose will be extrapolated to Day 29 (0-24 hr) and subtracted from the observed Day 29 concentration-time profiles after the first 30 mg ALXN1840 dose in order to determine the actual accumulation for the 30 mg dose level.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "9.4.4 Pharmacokinetic, Pharmacodynamic, and Biomarker Analyses",
      "pageNumber": 53
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "1f641f08-dfad-4136-9990-a2bf9c5dac27",
      "versionNumber": "Amendment 3.1 (US)",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2022-03-18",
      "description": "Substantial protocol amendment clarifying study procedures for US sites to facilitate participant recruitment and reduce inconvenience without compromising study quality.",
      "amendmentNumber": "3.1 (US)"
    },
    {
      "id": "0484c4aa-7c29-4312-8d40-c03f58c60c7f",
      "versionNumber": "Original Protocol",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-05-12",
      "description": "Initial version of protocol ALXN1840-WD-204 for the Phase 2 open-label study of ALXN1840 in Wilson disease."
    },
    {
      "id": "e4964066-6b4c-4e32-ba3c-78695053286a",
      "versionNumber": "Amendment 1",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-08-18",
      "description": "First protocol amendment; specific content not detailed in provided extract.",
      "amendmentNumber": "1"
    },
    {
      "id": "836ceadc-b20d-4145-b2a9-37dd26669734",
      "versionNumber": "Amendment 2",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-03-19",
      "description": "Second protocol amendment; specific content not detailed in provided extract.",
      "amendmentNumber": "2"
    },
    {
      "id": "7a4962ea-ff90-4b4a-afa5-f950f06143ef",
      "versionNumber": "Amendment 3",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-08-31",
      "description": "Third protocol amendment; specific content not detailed in provided extract.",
      "amendmentNumber": "3"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "08812d2d-6614-4334-87bc-fde4d10a41c6",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "affectedSection": "Overall Protocol (Amendment 3.1 (US))",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Substantial amendment to clarify study procedures across different US sites, facilitate recruitment, and lessen participant inconvenience without compromising study quality"
    },
    {
      "id": "68d911ad-88a0-424c-9108-677c60f2cb93",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "affectedSection": "Section 1.3 - Schedule of Activities (SoA), Table 1 (footnote)",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Addition of footnote text to reference US-specific screening site procedures described in Section 8"
    },
    {
      "id": "32969004-1026-4394-89b8-ff8ae4b663e6",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "affectedSection": "Section 4.2 - Scientific Rationale for Study Design",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Adjustment of the post-discontinuation interval for zinc from 30 days to 21 days in the scientific rationale text"
    },
    {
      "id": "45634943-bad2-4cb8-b155-bfa0bfda1ff5",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "affectedSection": "Section 8 - Study Assessments and Procedures",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Addition of US-only text allowing certain US sites to conduct screening procedures only, without performing remaining on-study procedures"
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "347be4aa-497d-4024-8099-d31b550f93de",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "reasonText": "The main reason for preparation of this amendment was to clarify study procedures occurring across different sites in the US, so as to facilitate participant recruitment across different regions of the US, and to lessen inconvenience for participants without compromising the quality of the study.",
      "category": "Operational",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "6d1b2af2-9b59-4fbe-bf3c-e04fc026fbb9",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "reasonText": "Addition of text to the Schedule of Activities footnote to state that procedures specific to US screening sites are detailed in Section 8, to keep the SoA aligned with the more detailed procedural description.",
      "category": "Operational",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "0780781d-0f61-4b4c-933e-a2e34390fe59",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "reasonText": "To align the number of days with the mention of zinc discontinuation elsewhere in the protocol.",
      "category": "Scientific",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "85eb94f6-cdab-4d21-8522-d8a86608ef23",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "reasonText": "To facilitate participant recruitment across different regions of the US and to lessen inconvenience for participants without compromising the quality of the study.",
      "category": "Operational",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "b0e61d82-5b4f-4170-b226-66b13db9d40b",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "1.3",
      "beforeText": "Schedule of Activities (SoA), Table 1 footnote text (exact prior footnote content not provided in the excerpt) did not reference Section 8 for US-only screening site procedures.",
      "afterText": "Footnote to Table 1 includes added text stating that procedures specific to screening sites (only in the US) are detailed in Section 8.",
      "summary": "Added SoA footnote language indicating that US screening-site–specific procedures are described in Section 8, to cross-reference newly added operational options for US screening-only sites."
    },
    {
      "id": "91bf6c82-a005-4f0e-bb24-cbc03675e234",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "4.2",
      "beforeText": "However, the physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014); therefore, the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
      "afterText": "However, the physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014); therefore, the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
      "summary": "Changed the post-zinc discontinuation interval in the scientific rationale from 30 days to 21 days to align with other protocol references to zinc washout duration."
    },
    {
      "id": "4015b3f9-0208-4da5-a4f7-dc1e323153d5",
      "amendmentId": "27115d5b-ac7e-4276-b2b4-a2f6ed7a4a7d",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "8",
      "beforeText": "Section 8 contained study assessments and procedures but did not specify that some US sites could function solely as screening sites, performing only screening procedures.",
      "afterText": "Section 8 includes additional text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures.",
      "summary": "Added US-only operational language to allow designated US sites to act as screening-only locations, with all non-screening study procedures conducted elsewhere."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "issues_found"
  }
}